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Chapter one
GENERAL INTRODUCTION
ALESSANDRA GENNARI
Research Institute of Toxicology, Immunotoxicology Section, Utrecht University,
PO Box 80.176, NL-3508 TD, Utrecht, The Netherlands
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1. ORGANOTIN COMPOUNDS
1.1 In general
Organotin compounds are chemicals with at least one covalent Sn-C bond. Dependent
on the number of organic moieties present, they are classified as mono-, di-, tri- or
tetraorganotins.
Dialkyltin compounds are widely applicated as polyvinyl chloride plastics (PVC)
stabilizers and industrial catalysts, while trialkyltin compounds are used as biocides in
agriculture and in anti-fouling paints in large shipping (Van der Kerk, 1978; Snoeij et al.,
1987, Penninks et al., 1991). The commercial uses of organotin compounds expanded
rapidly during the last 50 years: the wide application and the subsequent spread in the
environment urged the need for a thorough knowledge of organotin induced-toxicity,
which appeared to include hepatotoxicity, neurotoxicity, cutaneous toxicity and
immunotoxicity (Snoeij et al., 1987).
The present thesis is mainly focused on the study of both cellular and molecular
mechanisms underlying the immunotoxicity induced by organotins. The two classes of
compounds that have been most extensively studied in this respect are dialkyltin
homologues, such as di-n-butyltin dichloride (DBTC) and trialkyltin homologues, such as
tri-n-butyltin chloride (TBTC) (Seinen et al., 1977a; Seinen et al., 1977b; Vos et al.,
1984; Snoeij et al., 1988; Pieters et al., 1992, 1995a, 1995b; Vandebriel et al., 1999).
1.2 Organotin compounds and immunotoxicity
Both DBTC and TBTC are known to induce a dose-dependent and reversible reduction
of thymus weight and thymocyte number in rats (Seinen and Willems, 1976; Seinen et
al., 1977a; Snoeij et al., 1988). Histological investigations revealed a strong depletion of
lymphocytes in the thymic cortex, without signs of overt cell destruction (Seinen and
Willems, 1976; Penninks et al., 1985).
Phenotypical analyses of intrathymic changes after a single oral exposure of DBTC
(15-20 mg/kg body weight), showed an initial selective inhibition of the number of
immature proliferating thymoblasts (CD4-CD8-CD2highTcRαβ-/low and CD4-
CD8+CD2highTcRαβ-/low) within 1-2 days, resulting in a marked depletion of small
cortical CD4+CD8+ thymocytes on day 4-5 after dosing (Snoeij et al., 1988; Pieters et al.,
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1992). Comparative studies of histology and kinetics of the thymus atrophy were
remarkably similar for TBTC (Snoeij et al., 1986a). However, DBTC was found to be
more effective in inducing atrophy, and further kinetic investigations have indicated that
TBTC is metabolised to DBTC in the gastrointestinal tract (Snoeij et al., 1988).
Immature thymocyte proliferation has been shown to depend on cell contact between
thymocytes and thymic epithelial cells (TEC), and this binding, mediated by adhesion
molecules (Fox et al., 1985; Denning et al., 1987), can be disturbed by DBTC (Pieters et
al., 1995a). Being a potent thiol-reagent (Penninks and Seinen, 1983), DBTC might
modify the functioning of the adhesion molecules interfering with their cytoskeletal SH-
dependent organization (Geppert and Lipsky, 1991). Moreover, DBTC has been found to
enhance the TcRαβ-mediated Ca2+ response in both thymocytes and peripheral T cells,
although in case of thymocytes the increase was more pronounced. In the same study,
DBTC was found to inhibit capping of TcRαβ and CD8 molecules (Pieters et al., 1995b).
Also TBTC had effects on cytoskeletal proteins (Marinovich et al., 1990a) and on the
microfilament system. TBTC induced rapid depolymerization of thymocyte F-actin
content, through Ca2+-dependent and Ca2+-independent processes (Chow and Orrenius,
1994). Particularly, trialkyltins are known to perturbate the homeostasis of calcium,
inducing a rapid increase in cytosolic Ca2+ concentration (Chow et al., 1992).
Different in vivo studies with rats that received organotin compounds in diet for longer
than 2 weeks, showed a decrease not only in thymocyte number but also in the number of
peripheral T cells, as well as of T cell areas in spleen and lymph nodes (Seinen and
Willems, 1976; Vos et al., 1984). However, the total number of B cells in the spleen was
not significantly affected (Krajnc et al., 1984; Vos et al., 1990).
Parallel in vitro studies showed the general antiproliferative effect of DBTC and TBTC.
DBTC strongly reduced the mitogen-induced proliferation of splenic T and B
lymphocytes, as well as the spontaneous and mitogen-induced proliferation of
thymocytes (Seinen et al., 1979), and TBTC concentration-dependently reduced the
number of bone marrow cells (Snoeij et al., 1986b).
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1.3 Cellular and biochemical toxicity of organotin compounds
The cytotoxic effects of organotin compounds have been intensively investigated.
Diorganotin compounds inhibit the α-keto acid oxidizing enzyme complexes in
mitochondria. Since they have a high chemical affinity for dithiol groups, this inhibition
was suggested to be due to binding to lipoic acid or lypoyl dehydrogenase (Aldridge,
1976; Penninks and Seinen, 1980). At higher concentrations, DBTC was also found to
inhibit the oxidative phosphorylation processes in mitochondria (Cain et al., 1977;
Penninks et al., 1983). Dialkyltin can also affect cellular metabolism, provoking an
increase in the consumption of glucose and accumulation of pyruvate and lactate, but
without affecting the intracellular ATP levels in glucose-containing media (Penninks and
Seinen, 1980).
Triorganotins are effective inhibitors of mitochondrial ATP synthesis (Aldridge, 1976;
Snoeij et al., 1987). They mediate an exchange of hydroxyl ions across the mitochondrial
membranes, resulting in a disturbance of the existing proton gradient, and they bind to a
component of the ATP synthase complex, leading to an inhibition of ATP production.
Studies on cellular effects indicated an increase in the consumption of glucose and
accumulation of lactate, and a marked reduction of ATP level (Snoeij et al., 1986c).
Possibly related to the above-mentioned cytotoxic effects, organotin compounds
interfere with macromolecular synthesis (DNA, RNA and protein) in rat thymocytes. The
incorporation of thymidine into DNA and of L-proline or L-leucine into protein is
decreased by tributyltin and dibutyltin compounds, while the incorporation of uridine into
RNA is stimulated. For TBTC it has been demonstrated that this increase of RNA occurs
particularly in small thymocytes (Penninks and Seinen, 1983; Snoeij et al., 1986c).
2. APOPTOSIS
2.1 In general
Necrosis and apoptosis are two distinct modes of cell death (Fig. 1). During necrosis the
permeability of the plasma membrane increases, the endoplasmic reticulum dilates, the
cell alters shape with blebbing of the surface, the mitochondria become denser, the
nuclear chromatin flocculates, and cell releases lysosomal enzymes that may provoke an
inflammation reaction.
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A cell undergoing apoptosis rounds up, severing junctions with its neighbours and
losing microvilli. The cytoplasm condenses, but the plasma membrane, ribosomes, Golgi
apparatus, and mitochondria remain intact. The endoplasmic reticulum dilates, forming
vesicles that fuse with the surface membrane giving a characteristic bubbling appearance.
The chromatin condenses at the nuclear membrane and the cell separates into apoptotic
bodies that are recognized, phagocytosed and digested by macrophages or epithelial cells.
In this way dead cells are rapidly removed, and any leakage of their possibly dangerous
contents is avoided.
Fig. 1. Morphologic characteristics of necrosis and apoptosis, two distinct patterns of cell death.
Adapted from Duvall and Wyllie (1986).
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Apoptosis is the mechanism of cell death underlying programmed cell death during
embryogenesis, and as such crucial for maintenance of tissue shape and cell renewal. In
the immune system, apoptosis is an important homeostatic process in normal tissue
physiology, where it mediates the silencing of autoreactive precursor cells during T and B
cell development and eliminates expanded clones at the termination of an immune
response. Regulation of apoptosis involves signal transduction networks as complex as
those regulating cell proliferation and differentiation (McConkey et al., 1994). Defects in
the control of apoptosis have been linked to various diseases, including autoimmunity
(Ravirajan, et al., 1999), neurodegenerative diseases (Raff et al., 1993), and acquired
immunodeficiency syndrome (AIDS) (Gougeon and Montagnier, 1993).
2.2 Nuclear changes
In the nucleus, the chromatin is condensed at the nuclear membrane and then degraded
into fragments, all integer multiples of about 190 base pairs of DNA (Wyllie and Morris,
1982). This pattern of cleavage is due to the vulnerability of the linker DNA between
nucleosomes to various Mg2+ and Ca2+-dependent endonucleases. DNA fragmentation is
a very important hallmark of apoptosis, and can be made visible on agarose gels (so-
called DNA laddering).
2.3 Ca2+ and cytoskeleton alterations
Normal cytoskeletal organization is essential for several cellular processes. Disruption
of this organization results in the appearance of surface protrusions known as blebs,
which can rupture, compromising plasma membrane integrity. The involvement of Ca2+
in the appearance of surface abnormalities has been suggested by the observation that
blebs occur when cells are treated with toxic agents that cause a sustained increase in
cytosolic Ca2+ level. Ca2+ is also involved in the interactions between the various
structural components of the cytoskeleton, via Ca2+-binding proteins and Ca2+-dependent
enzymes (Orrenius et al., 1989). In particular, the association of the cytoskeletal network
with the plasma membrane and the interaction of different classes of cytoskeletal fiber
appear to be strictly dependent on the cytosolic Ca2+ level. An increase in cytosolic Ca2+
concentration causes the cleavage of actin microfilaments from α-actinin, disturbing the
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association with the plasma membrane and leading to the production of surface blebs,
which is one of the characteristic morphological alterations during apoptosis.
Ca2+ has been shown to mediate endonuclease activation, which results in the cleavage
of target-cell chromatin into oligonucleosome fragments. Intracellular calcium chelators
and extracellular EGTA can inhibit DNA fragmentation and apoptotic cell death,
suggesting that sustained Ca2+ elevations are required for both responses (McConkey et
al., 1989; Aw et al., 1990).
2.4 Cell surface alterations
It is characteristic of apoptotic cells that they are rapidly recognized and phagocytosed
by their neighbours or macrophages. It seems that recognition of apoptotic cells involves
existing specific receptors on acceptor cells binding to newly exposed ligands on
apoptotic cells (Arends and Wyllie, 1991). One common parameter for detection of
apoptosis is the presence of phosphatidyl serines (Fadok et al., 1992), which are normally
located inside the plasma membrane, at the extracellular side.
2.5 Macromolecular synthesis
Several studies showed that apoptosis is an active, energy-requiring process, and that
the synthesis of a new protein or proteins is most likely required for programmed cell
death to occur. This has been confirmed by the finding that apoptosis can be prevented by
inhibitors of synthesis of RNA (actinomycin D) and protein (cycloheximide) in different
cell types and circumstances (Wyllie et al., 1984; Compton et al., 1988; Martin et al.,
1988; Lanotte et al., 1991).
2.6 Mitochondria-cytochrome c
Numerous recent finding suggest that mitochondria have a central role in the apoptotic
process (Marchetti et al., 1996; Kroemer, 1997a). Two different major changes in
membrane permeability have been observed. Firstly, the electrochemical gradient built up
over the mitochondrial inner membrane dissipates during apoptosis (Zamzami et al.,
1995). Secondly, proteins that normally are sequestered in mitochondria are released
through the outer mitochondrial membrane to the cytosol. Such proteins include
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cytochrome c, which functions as an electron carrier in the respiratory chain (Liu et al.,
1996).
The exact molecular mechanisms and the cause/effect relationship between the increase
in inner and outer mitochondrial membrane permeability are still not completely clear. It
has been hypothesized that opening of the so-called mitochondrial permeability transition
pore (PT), which is formed by proteins within the contact site of the inner and outer
membranes, might be closely linked to both the dissipation of the inner transmembrane
potential (∆Ψ) and the cytochrome c release (Kroemer, 1997b).
2.7 Reactive oxygen species (ROS)
As the terminal electron acceptor for oxidative phosphorylation, molecular oxygen
occupies an essential role in many of the metabolic processes associated with an aerobic
existence. However, this thirst for electrons also leads to the formation of a variety of
reactive oxygen intermediates, oxygen species that have either unpaired electrons (i.e.
O-2, OH•) or the ability to abstract electrons from other molecules (i.e. H2O2) (Halliwell
and Gutteridge, 1990). Reactive species react with cellular macromolecules, damaging
them directly or indirectly. Consequences of ROS toxicity include protein alterations,
nucleic acid damage or oxidation of membrane lipids, which result in the loss of plasma
membrane integrity. Mitochondria are believed to be an important source for ROS
production (Corsini et al., 1998). It has been shown that many of the chemicals capable
of inducing apoptosis are also associated with oxidative stress, suggesting an active role
for reactive oxygen species in cell death (Buttke and Sandstrom, 1994).
2.8 Caspase family
Overwhelming evidence suggests the involvement of specific cysteine aspartate-specific
proteases (caspases) in apoptosis (Kumar and Lavin, 1996; Zhivotovsky et al., 1997).
Caspases catalyse a highly selective pattern of protein degradation, and are all
synthesised as proenzymes that are proteolytically processed to form active enzymes. The
cleavage sites for proteolytic maturation of procaspases are themselves cleaved by
caspases, suggesting that caspases may engage in a cascade of activation and
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amplification steps (Hirata et al., 1998). Different proteins, with an important role in
causing cell death, can be digested by caspases (Penninger and Kroemer, 1998).
At least 14 different caspases have been identified in man (Van de Crean et al., 1998),
but in particular the subfamily of caspase 3-like proteases, including caspase 3, 6, 7 and
9, seems to be involved in apoptosis. These enzymes mediate apoptosis by cleaving
selected intracellular proteins such as proteins of the nucleus, nuclear lamina,
cytoskeleton, endoplasmatic reticulum, and cytosol (Kumar and Lavin, 1996).
Furthermore, the activation of caspase 3 seems to be preceded by the release of
mitochondrial cytochrome c (Bossy-Wetzel et al., 1998).
3. ORGANOTIN COMPOUNDS AND APOPTOSIS
Physiologic triggers are not the only ones capable of inducing apoptosis in susceptible
target cells, and many chemicals exert their effects by stimulating apoptosis by exploiting
physiologic control mechanisms.
The combination of cytotoxic effects of DBTC and TBTC (Cain et al., 1977; Snoeij et
al., 1987; Marinovich et al., 1990b) have suggested that organotins might induce
apoptosis in thymocytes and possibly other cells, and in fact this has been demonstrated
to be the case for TBT-compounds. DBTC appeared unable to significantly increase
DNA fragmentation in vitro, although only one concentration at one time point was tested
(Aw et al., 1990; Raffray and Cohen, 1993).
It has been shown that the interaction between micromolar concentrations of TBTC and
the thymocyte plasma membrane causes the opening of Ca2+ channels, which leads to a
sustained elevation of cytosolic Ca2+. The latter stimulates an endogenous endonuclease
activity and directs thymocytes into apoptosis (Aw et al., 1990; Chow et al., 1992). More
recently, Corsini et al. (1998) demonstrated in murine keratinocytes that TBTC induced
ROS production at the mitochondrial level, which is preceded by alterations of Ca2+
homeostasis. Furthermore, targeting of mitochondria by TBTC has been shown capable
to release pro-apoptotic factors, such as cytochrome c, considered as a primary event in
the induction of DNA fragmentation (Liu et al., 1996; Kroemer, 1997). TBTC induced
the release of cytochrome c from the mitochondrial intermembrane space into the cytosol
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in Jurkat cells and subsequently activated caspase 3, which leads to the irreversible
damage of the cell (Stridh et al., 1998).
In vivo experiments showed that apoptotic cell death occurs in the thymus after
exposure to relatively high doses of tributyltin-oxide (TBTO) (Raffray and Cohen, 1993).
4. AIM OF THE THESIS
Over the past 10 to 20 years many attempts have been made to identify the mechanism
involved in organotin-induced thymus atrophy (Krajnc et al., 1984; Vos et al., 1984;
Penninks et al., 1985, 1991; Snoeij et al., 1987, 1988; Marinovich et al., 1990a; Pieters et
al., 1992, 1995a, 1995b). Although considerable progress has been made, the apparent
discrepancy between the thymus selectivity in vivo, and the general antiproliferative
effect in vitro, has hampered inclusion of specific in vitro data in a mechanism that might
explain the in vivo observations. The absence of any sign of apoptosis in vivo after
exposure to selective anti-proliferative doses of organotins, and the findings indicating
that TBT-compounds are rapidly metabolised into DBT-compounds, are considered as
additional confusing factors. The aim of this project was therefore to further elucidate the
mechanisms underlying thymus atrophy induced by the organotin compounds TBTC and
DBTC by focusing on the following two issues:
 Apoptosis in relation to dose and concentration: has apoptotic cell death a role in
the thymus at antiproliferative doses? Is DBTC also able to induce apoptosis in
vitro? Is there a similarity in the mechanism of apoptosis between TBTC and
DBTC?
 Thymus selectivity: is the thymus sensitive because it is a highly proliferative
organ or do organotins have a wider anti-proliferative effect?
The second chapter evaluates the importance of DNA fragmentation in thymus atrophy
induced by organotin compounds, at doses known to specifically affect thymocyte
proliferation. The finding that apoptosis is not relevant in vivo at anti-proliferative doses
of DBTC or TBTC, but may be so at higher doses, pushed us to focus on in vitro
induced-apoptosis by organotins, in order to elucidate the molecular (RNA and protein)
and cellular (calcium, mitochondria, cytochrome c and caspases) mechanisms involved in
this kind of cell death (chapter 3 and 5). In chapter 4, the use of a recently developed
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technique, called cDNA array assay, helped us to visualize some of the genes up
regulated by organotin compounds during in vitro apoptosis. Finally, an in vivo study is
performed to evaluate whether anti-proliferative organotin compounds are really thymus-
specific or rather have a generally antiproliferative and immunosuppressive effect
(chapter 6). Chapter 7 summarizes and discusses the contents of this thesis.
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ABSTRACT
The organotin compounds di-n-butyltin dichloride (DBTC) and tri-n-butyltin chloride
(TBTC) selectively cause thymus atrophy. Previously, DBTC and TBTC were shown to
inhibit proliferation of immature thymocytes, but other studies demonstrated that TBTC
but not DBTC increased apoptosis in vitro and also in vivo. In this study we examined
whether apoptosis is increased in vitro by DBTC and TBTC at various concentrations and
periods of incubation, and whether apoptosis is involved in the induction of thymus
atrophy at selective antiproliferative doses. In vitro, DBTC or TBTC at a concentration of
3 µM significantly increased DNA fragmentation in freshly isolated rat thymocytes after
preincubation for 10 min followed by a 22-hr culture period. After continuous exposure
for 22 hr, apoptosis was observed to be optimum at 1 µM TBTC and 0.3 µM DBTC and
lower or absent at higher concentrations. Apparently, apoptosis induced by organotins in
vitro depends on both duration and concentration of exposure. Selective antiproliferative
doses of DBTC nor TBTC increased apoptosis on day 1 or 2 after single oral exposure. In
contrast, the corticosteroid dexamethasone caused a depletion of both small and large
thymocytes and a marked increase of apoptosis on both days 1 and 2 after dosing. Thus,
although apoptosis is involved in the in vitro cytotoxic effects of both organotin
compounds, it seems not involved in thymus atrophy at a dose that selectively inhibits
immature thymocyte proliferation.
INTRODUCTION
Organotin compounds are in use in various industrial and agricultural applications.
Derivatives of dialkyltin compounds like di-n-butyltin dichloride (DBTC) are in use as
PVC stabilizers and industrial catalysts, whereas trialkyltin compounds, such as tri-n-
butyltin chloride (TBTC), are potent biocides in crop protection and anti-fouling paints
for large shipping (Fent, 1996).
Both organotins cause thymus atrophy and, after prolonged exposure, suppress T-cell-
mediated immune responses (Seinen and Willems, 1976; Seinen et al., 1977, 1979; Vos
et al., 1984). Previous kinetic studies have indicated that TBTC is dealkylated to DBTC
and that DBTC is the toxicologically active compound (Snoeij et al., 1988). Subsequent
mechanistic studies have therefore focussed on the thymic effects of DBTC as the most
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suitable thymotoxic model organotin compound. After single oral exposure to DBTC
(15 mg/kg) a maximum depletion of the large population (80-85% of all thymocytes) of
small cortical CD4+CD8+ thymocytes occurred 4 to 5 days later (Pieters et al., 1992).
Importantly, this depletion was preceded by a maximum decrease in the number of
immature proliferating thymoblasts at 24-48 hr after dosing. Additional phenotypical
analyses of the early thymic effects in combination with the fast turnover of the
CD4+CD8+ thymocyte population, suggest that organotin-induced thymus atrophy is
initiated by selective inhibition of the proliferation of immature CD4-CD8+ thymocytes.
This population constitutes a highly proliferative subset in transcience between the very
immature CD4-CD8- TcRαβ-/low and the more mature CD4+CD8+TcRαβ-/low population
(Snoeij et al., 1988; Pieters et al., 1993).
Recently, it has been shown that increased apoptotic cell death may be an alternative or
additional cause in TBTC-induced thymus atrophy (Raffray and Cohen, 1993). DBTC
was not tested in vivo, but appeared unable to induce a substantial increase in apoptosis in
vitro, although only one concentration at one time point was tested (Aw et al., 1990;
Raffray and Cohen, 1993). As TBTC is likely to be dealkylated to DBTC in vivo and
because of our previous findings that inhibition of proliferation underlies organotin-
induced thymus atrophy, we investigated whether DBTC or TBTC induces apoptosis at
selective antiproliferative doses. Moreover, as cytotoxicity of TBTC depends on the
concentration and duration of exposure (Zucker et al., 1992), we set out to determine if
DBTC increases DNA fragmentation in vitro at varying concentrations and/or time
periods of incubations.
MATERIALS AND METHODS
Chemicals and solutions
DBTC was obtained from Johnson Matthay Alfa Products (Karlsruhe, Germany), TBTC
was a gift from Dr. H. Meinema (TNO, Zeist, The Netherlands) and dexamethasone
(DEX) was purchased from Sigma (St. Louis, MO). Propidium Iodide (5 µg/ml PI,
Sigma) was dissolved in PBS. Ribonuclease A (RNase, type I-A, Sigma) was dissolved
first in Tris buffer (10 mg/ml), boiled for 15 min, and then diluted in RNase buffer (0.1%
sodium citrate, 0.1% Triton X-100) to obtain a final concentration of 0.5 mg/ml.
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5-Bromo-4-indolylphosphate (BCIP, Boehringer Mannheim, B.V., Almere, The
Netherlands) was dissolved in N,N-dimethylformamide and nitroblue tetrazolium (NBT,
Sigma) was dissolved in bidest. RPMI-1640 (Gibco, Paisley, UK) was supplemented with
5% heat-inactivated fetal calf serum (Gibco), 1% glutamine (Gibco), penicillin/
streptomycin (Flow, Irvine, UK), and sodium bicarbonate (Gibco), 1% Hepes buffer
(Gibco). PBS was supplemented with 4 mM Ca2+ and 10 mM Mg2+ and when used for
preparation of cell suspensions also with 2 mM glucose.
Animals and treatment
Male Wistar-derived rats (U:Wu) were bred under specific pathogen-free conditions and
housed under standard conditions (room temperature ±20°C, relative humidity ±55%) in
the breeding facilities of the Utrecht University (Utrecht, The Netherlands). Rats were 4-
5 weeks of age at the start of the experiments, because at that age their thymus is optimal
of size and effects of organotins are most pronounced compared to controls (Seinen and
Willems, 1976; Snoeij et al., 1988; Pieters et al., 1992).
For the in vivo studies, animals (four per group) were intubated with a dose of 20 mg
DBTC or TBTC/kg body wt. Previously, this dose was shown to cause thymus weight
reduction to about 50% of control (Snoeij et al., 1988). The organotins were dissolved in
ethanol absolute (Merck, Darmstadt, Germany) and further diluted in corn oil (250 ml per
rat) to a final ethanol concentration of 5% (v/v). Dexamethasone (3 mg/kg body wt) was
dissolved in saline and given intraperitoneally. Control rats were intubated with the same
volume of corn oil (250 µl, 5% ethanol) without organotin compounds. Rats were killed
by decapitation and thymi were isolated. Half of the thymus was then snap-frozen in
liquid N2 and the other part was used to prepare cell suspensions.
Cell suspensions and incubation
Cell suspensions from thymi and spleens were prepared by crushing the organs on a
nylon sieve and collecting the cells in ice-cold PBS. After centrifugation, cells were
resuspended in RPMI-1640 or, for the thymocytes obtained from the in vivo treated rats,
in PBS and counted by a Coulter counter ZM (Coulter Electronics, Luton, UK). In case of
thymocytes, numbers of total cells (diameter>4.3 µM) and large cells (diameter>8.2 µM),
Chapter 2
27
representing proliferating thymoblasts, were determined as described before (Snoeij et
al., 1988) by varying the threshold values on the Coulter counter.
For in vitro incubations, DBTC, TBTC, and DEX (final concentration, 10 µM) were
dissolved in ethanol absolute and then diluted in RPMI. The final ethanol concentration
was 0.1%, which was ineffective by itself. Cells were incubated for 10 min, washed
twice, and incubated overnight (about 22 hr) without the compounds or were incubated
continuously for 22 hr with varying concentrations of organotins at 37°C. DEX was
present throughout the whole incubation period of 22 hr.
Detection of apoptosis
By flow cytometry. Detection of DNA fragmentation by flow cytometry with PI as
fluorescent indicator was done essentially as described by Nicoletti et al. (1991). Briefly,
after incubation with the test compounds, 5x106 cells/ml were centrifuged and
resuspended in 1 ml PBS. Of this cell suspension 200 µl was incubated for 30 min with
0.5 ml RNase (0.5 mg/ml) at room temperature. Then, 0.5 ml PI was added (5 µg/ml) and
the fluorescence of individual nuclei was measured (in the FL2 channel set for log scale)
on a FACScan flow cytometer (Becton-Dickinson, Erembodegem, Belgium).
By in situ labeling. The immunohistochemical in situ cell death detection kit of
Boehringer Mannheim was used essentially according to the manufacturer's instructions.
Briefly, frozen tissue sections were fixed with 4% paraformaldehyde, washed with PBS,
and incubated with permeabilisation solution (0.1% Triton X-100 in 0.1% sodium
citrate). After washing, 50 µl TUNEL reaction mixture (label solution + enzyme solution)
was first added on each section followed by 50 µl of converter-AP (alkaline phosphata-
se). Finally, the substrate solution (18 mg/ml BCIP, 5 mg/ml NBT, Tris/HCl/Mg buffer)
was added and the labeled DNA strandbreaks were analyzed by light microscopy.
Statistics
One-way ANOVA with Scheffe’s post hoc test was used to assess significance of
differences between group means. p values < 0.05 were considered significant.
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RESULTS
DBTC and TBTC increase apoptosis in vitro
Freshly isolated rat thymocytes kept overnight at 37°C without further treatment already
showed an increase of DNA fragmentation when compared to thymocytes stored
overnight at 4°C (data not shown). The extent of fragmentation at 37°C was the same
after incubation with the solvent ethanol (0.1%, v/v) and considered background. After
incubation for 10 min with either DBTC or TBTC followed by two washes, the
percentage of apoptotic nuclei was increased after a culture period of 22 hr (Fig. 1A).
This effect appeared dose-dependent but was only statistically significant at 3 µM for
both organotins. After continuous exposure for 22 hr, an optimum in DNA fragmentation
was observed at 1 µM for TBTC and 0.3 µM for DBTC (Fig. 1B). At 1 µM DBTC DNA
fragmentation was at background level whereas at 3 µM DBTC the percentage of DNA
fragments was as low as the 0°C control.
Organotins have been shown to selectively decrease thymus weight, without affecting
spleen weight or morphology (Vos et al., 1984; Snoeij et al., 1988). To assess whether
the apoptotic effects of organotins were selective in vitro as well, we have tested whether
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Fig. 1. Relative DNA fragmentation in thymocytes incubated in vitro with graded concentrations of DBTC
or TBTC as measured by flow cytometry. 0°C, DEX, and ethanol served as controls. (A) 10-min
preincubation; (B) 22-hr continuous exposure. *p<0.05.
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organotin induces apoptosis in spleen cells. As shown in Fig. 2, spleen cells treated for 10
min with DBTC or TBTC and then cultured 22 hr without compounds demonstrated
DNA fragmentation.
Fig. 2. Relative frequency of DNA fragmentation in spleen cells in vitro induced by the organotin
compounds DBTC or TBTC after a 10-min preincubation. DEX and ethanol served as controls. Histograms
are from one representative experiment out of three.
DBTC and TBTC do not induce apoptosis in vivo
One day after injection of the positive control DEX (3 mg/kg), ±22 % of the DNA
collected from thymi was fragmented as assessed by flow cytometry (Fig. 3). By
immunohistology a massive increase of apoptotic cells was demonstrated in the thymus
cortex (Fig. 4). On day 2 after dosing, the percentage of apoptosis was reduced (data not
shown), which may be due to phagocytic activity of reticular cells or macrophages in the
thymus (Boyd et al., 1993).
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In contrast, no DNA fragmentation was detected by flow cytometry (Fig. 3) and no
increase of apototic cells was detected in situ (Fig. 4) on any of the 2 days after oral
treatment with DBTC or TBTC.
Fig. 3. Flow cytometry of PI-stained
nuclei of thymocytes obtained from rats
treated with corn oil (CON), DEX,
DBTC or TBTC, 24 hr after dosing.
Histograms are from one representative
animal of four per treatment.
Organotin compounds, unlike DEX, selectively decrease the number of large thymocytes
On day 1, the number of both total and large cells was profoundly reduced in DEX-
treated rats when compared to controls or organotin-treated rats. Organotin treatment did
not affect the number of total cells, whereas the number of large cells tended to decrease
compared to controls (Table 1).
On day 2, absolute thymocyte numbers in control animals seemed increased compared
to day 1, but this was not significant and possibly the result of the still growing thymus in
these young rats. On the same day, organotins caused a decrease in total number of
thymocytes to around 50-60% of control, whereas the number of large cells was around
30% of control. DEX was less selective as it reduced the number of total and large
thymocytes to around 9 and 12 % of control, respectively (Table 1).
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Fig. 4. Immunohistochemical staining for apoptosis on thymus sections obtained from control rats (A), or
DBTC (B)-, TBTC (C)- or DEX (D)-exposed rats, 24 hr after dosing. Magnification 200x.
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Fig. 4. - continued
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Table 1. Number of total and large thymocytes per thymus on days 1 and 2 after dosing.
DAY 1 DAY 2
Compound Total Large Total Large
Control 70.8 ± 17.9 3.7 ± 1.0 102.5 ± 14.1 5.0 ± 0.6
DEX 19.8 ± 4.6* 0.7 ± 0.1* 9.2 ± 10.6* 0.6 ± 0.5*
TBTC 71.6 ± 17.8 2.8 ± 0.7 59.2 ± 22.3** 1.6 ± 0.9*
DBTC 87.0 ± 9.4 3.0 ± 0.2 61.5 ± 25.1** 1.3 ± 0.6*
Note. cell numbers (x107) are given as mean ± S.D., n=4.
* p < 0.05, compared to groups not indicated. ** p< 0.05, organotins compared to control.
DISCUSSION
In the present study it is shown that both DBTC and TBTC induce DNA fragmentation
in freshly isolated rat thymocytes as well as splenocytes. In vivo data, however,
demonstrate that in contrast to the glucocorticosteroid DEX, neither of these compounds
increases the incidence of apoptotic cells in the thymus after a single oral dose (20
mg/kg) that selectively inhibits proliferation of immature thymocytes at 24-48 hr after
exposure (Snoeij et al., 1988; Pieters et al., 1992; Table 1).
In vitro, both organotin compounds significantly increase apoptosis after short-term (10
min) incubation at the relatively high concentration of 3 µM, whereas after continuous
exposure for 22 hr an optimum in DNA fragmentation was observed at 1 µM TBTC or
0.3 µM DBTC. Apparently, like other in vitro effects of TBTC (Zucker et al., 1992),
induction of apoptosis by TBTC or DBTC depends on both concentration and time of
incubation. Thus, at higher concentrations and after prolonged exposure organotins may
induce necrotic instead of apoptotic cell death, resulting in decreased DNA
fragmentation. This may also explain why others (Aw et al., 1990; Raffray and Cohen,
1993) could not detect DNA fragmentation in thymocyte suspensions after 1-6 hr of
incubation at concentrations over 0.3 µM DBTC.
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Thymus atrophy induced by DEX was clearly distinguishable from the one induced by
organotins. Notably, DEX caused a dramatic decrease in the number of both total and
large thymocytes and induced a profound increase of DNA fragmentation on day 1 and
less on day 2 after dosing. The fast kinetics and nonselective decrease in size-
characterized subpopulations seem typical for glucocorticoid-induced thymus atrophy
(Lundberg, 1991) and strengthen the idea that the thymotoxic effects of organotins at
relevant doses are not caused by stress-induced elevation of glucocorticosteroids (Seinen
and Willems, 1976; Snoeij et al., 1988).
The absence of apoptosis 1 or 2 days after DBTC or TBTC treatment is evidenced by
flow cytometry and by in situ staining of DNA strandbreaks, whereas a previous study
using the in situ BrdU method revealed an almost complete absence of proliferating cells
on day 2 (Pieters et al., 1993a,b). Our present in vivo findings with TBTC contradict a
previous study showing an increase in the incidence of DNA fragmentation 48 hr after
single oral dosing of 30 or 60 mg TBTC/kg (Raffray and Cohen, 1993). However, part of
this relative increase in apoptosis may be explained by the organotin-induced
phenotypical shift in thymocyte subsets on day 2, which is characterized by a decrease of
immature proliferating CD4-CD8+ and CD4+CD8+ cells and a relative increase of small
and apoptotic CD4+CD8+ thymocyte subset (Pieters et al., 1992). As these immature
proliferating cells are less prone to apoptosis (Scollay et al., 1988; Kendall, 1990; Cohen,
1991) this shift may cause a relative increase in apoptosis. In addition, although no
increases in adrenal weights were observed (Raffray and Cohen, 1993) stress-induced
thymotoxicity cannot be excluded at the relatively high doses of 30 and 60 mg TBTC/kg
body wt, as previous studies indicate that single doses over 20-35 mg TBTC/kg also
reduce spleen and body weights (Snoeij et al., 1988).
Data together indicate that apoptosis may be involved in organotin-induced thymus
atrophy at high doses, but it is not evident at lower doses that selectively inhibit immature
thymocyte proliferation. It should be noted here that both organotin compounds very
effectively inhibit proliferation of thymocytes in vitro at concentrations as low as 0.1 µM
(Snoeij et al., 1986; Pieters et al., 1994). Combined with the observation that these
thymus-selective organotins also induce apoptosis in isolated spleen cells and do not
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accumulate in the thymus (Penninks et al., 1987), this also argues against the relevance of
apoptosis in the initiation of thymus atrophy at antiproliferative doses.
In summary, we demonstrate that although both thymotoxic organotin compounds
DBTC and TBTC induce apoptosis in vitro at relatively high concentrations, apoptosis is
not likely to be involved in organotin-induced thymus atrophy at a dose that selectively
inhibits immature thymocyte proliferation. Organotin compounds are nevertheless very
useful in examining mechanisms of chemical-induced apoptosis in vitro, considering that
both DBTC and TBTC have a typical mode of action in causing DNA fragmentation
(McConkey et al., 1994), which is dissimilar and even antagonistic from the one induced
by glucocorticosteroids or via the T cell receptor (Zucker et al., 1994).
ACKNOWLEDGEMENTS
We would like to thank Rob Bleumink for preparing photographs and Dr. Cees de Heer
and Dr. Ruud Albers for critically reading the manuscript.
Chapter 2
38
REFERENCES
Aw, T. Y., Nicotera, P., Manzi, L., and Orrenius, S. G. (1990). Tributyltin stimulates apoptosis in
rat thymocytes. Arch. Biochem. Biophys. 283, 46-50.
Boyd, R. L., Tucek, C. L., Godfrey, D. I., Izon, D. J., Wilson, T. J., Davidson, N. J., Bean, A. G.
D., Ladyman H. M., Ritter M. A., and Hugo P. (1993). The thymic microenvironment.
Immunol. Today. 14, 445-459.
Cohen, J. J. (1991). Programmed cell death in the immune system. Adv. Immunol. 50, 55-85.
Fent, K. (1996). Ecotoxicology of organotin compounds. Crit. Rev. Toxicol. 26, 1-117.
Kendall, M. D. (1990). The cell biology of cell death in the thymus. In Thymus Update Vol. 3,
The Role of the Thymus in Tolerance Induction (M.D. Kendall, M.A. Ritter, Eds.), pp. 53-
76. Harwood Academic Publishers, London.
Lundberg, K. (1991). Dexamethasone and 2,3,7,8-Tetrachlorodibenzo-p-dioxin can induce
thymic atrophy by different mechanisms in mice. Biochem. Biophys. Res. Comm. 178, 16-
23.
McConkey, D. J., Jondal, M. B., and Orrenius, S. G. (1994). Chemical-induced apoptosis in the
immune system. In Immunotoxicology and Immunopharmacology. Second edition (Dean, J.
D., Luster, M. I., Munson, A. E., Kimber, I.). pp. 473-485. Raven Press, New York.
Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F. , and Riccardi, C. (1991). A rapid and
simple method for measuring thymocyte apoptosis by propidium iodide staining and flow
cytometry. J. Immunol. Meth. 139, 271-279.
Penninks, A. H., Hilgens, L., and Seinen, W. (1987). The absorption, tissue distribution and
excretion of di-n-octyltin dichloride in rats. Toxicology. 44,107-120.
Pieters, R. H. H., Bol, M., Lam, B. W., Seinen, W., and Penninks, A. H. (1992). The organotin-
induced thymus atrophy, characterized by a depletion of CD4+CD8+ thymocytes, is
preceded by a reduction of the immature CD4-CD8+TcRαβ-/lowCD2high thymoblast subset.
Immunology 76, 203-208.
Pieters, R. H. H., Bol, M., Lam, B. W., Seinen, W., Bloksma, N., and Penninks, A. H. (1993)
Recovery from chemically induced thymus atrophy starts with CD4-CD8-CD2highTcRαβ-
/low thymocytes and results in an increased formation of CD4-CD8-TcRαβhigh thymocytes.
Immunology 78, 616-622
Chapter 2
39
Pieters, R. H. H., Bol, M., Ariens, T., Punt, P., W., Seinen, W., Bloksma, N., and Penninks, A. H.
(1994). Selective inhibition of immature CD4-CD8+ thymocyte proliferation but not
differentiation, by the thymus atrophy-inducing compound di-n-butyltin dichloride.
Immunology 81, 261-267.
Raffray, M., and Cohen, G. M. (1991). Bis(tri-n-butyltin)oxide induces programmed cell death
(apoptosis) in immature rat thymocytes. Arch. Toxicol. 65, 135-139.
Raffray, M., and Cohen, G. M. (1993). Thymocyte apoptosis as a mechanism for tributyltin-
induced thymic atrophy in vivo. Arch. Toxicol. 76, 231-236.
Scollay R., Wilson, A., D’Amico, A., Kelly, K., Egerton, M., pearse M., Wu, L., and Shortman,
K. (1988). Developmental status and reconstitution potential of subpopulations of murine
thymocytes. Immunol. Rev. 104, 81-120.
Seinen, W., and Willems, M. I. (1976). Toxicity of organotin compounds. I. Atrophy of thymus
and thymus-dependent lymphoid tissue in the rat fed di-n-octyltindichloride. Toxicol. Appl.
Pharmacol. 35, 63-75.
Seinen, W., Vos, J. G., Van Krieken, R., Penninks, A. H., Brands, R., and Hooykaas, H. (1977).
Toxicity of organotin compounds. III. Suppression of thymus-dependent immunity in rats
by di-n-butyltin dichloride and di-n-octyltindichloride. Toxicol. Appl. Pharmacol. 44, 213-
224.
Seinen, W., Vos, J. G., Brands, R., and Hooykaas, H. (1979). Lymphotoxicity and
immunosuppression by organotin compounds. Suppression of GvH activity, blast
transformation, and E-rosette formation by di-n-butyltindichloride and di-n-
octyltindichloride. Toxicol. Appl. Pharmacol. 1, 343-355.
Snoeij, N. J., Van Iersel, A., Penninks, A. H., and Seinen, W. (1986). Triorganotin-induced
cytotoxicity to rat thymus, bone marrow and red blood cells as determined by several in
vitro assays. Toxicology. 39, 71-83.
Snoeij, N. J., Penninks, A. H., and Seinen, W. (1988). Dibutyltin and tributyltin compounds
induce thymus atrophy in rats due to a selective action on thymic lymphoblasts. Int. J.
Immunopharmacol. 10, 891-899.
Vos, J. G., De Klerk, A., Krajnc, E. I., Kruizinga, W., Van Ommen, B., and Rozing J. (1984).
Toxicity of bis(tri-n-butyltin)oxide in the rat. II Suppression of thymus-dependent immune
responses and of parameters of nonspecific resistance after short-term exposure. Toxicol.
Appl. Pharmacol. 75, 387-408.
Chapter 2
40
Zucker, R. M., Massaro, E. J., and Elstein, K. H. (1992). The reversibility of tributyltin-induced
toxicity in vitro as a function of concentration and duration of exposure (CxT). Environ.
Res. 57, 107-116.
Zucker, R. M., Elstein, K. H., Thomas, D. J., and Rogers J. M. (1994). Tributyltin and
dexamethasone induce apoptosis in rat thymocytes by mutually antagonistic mechanisms.
Toxicol. Appl. Pharmacol. 127, 163-170.
Chapter 3
41
Chapter three
ORGANOTIN-INDUCED APOPTOSIS OCCURS IN SMALL CD4+CD8+
THYMOCYTES AND IS ACCOMPANIED BY INCREASED RNA SYNTHESIS
ALESSANDRA GENNARI, MARIANNE BOL, WILLEM SEINEN, ANDRÉ PENNINKS* AND
RAYMOND PIETERS
Research Institute of Toxicology, Immunotoxicology Section, Utrecht University,
PO Box 80.176, NL-3508 TD, Utrecht, The Netherlands
*TNO-Nutrition and Food Research Institute, Zeist, The Netherlands
Chapter 3
42
ABSTRACT
The organotin compounds di-n-butyltin dichloride (DBTC) and tri-n-butyltin chloride
(TBTC) are known to induce thymus atrophy in rats, by interfering with immature
thymocyte proliferation. Higher doses of tributyltin compounds also induce apoptotic cell
death. In vitro, a similar concentration-dependency was observed, i.e. low concentrations
of organotins inhibit DNA synthesis and higher concentrations induce apoptosis. The
mechanism of apoptosis by organotins is not exactly known, but their capacity to
effectively inhibit protein synthesis seems to contradict with the idea that macromolecular
synthesis is required for apoptosis. Therefore, we aimed to evaluate the relation between
apoptosis and the synthesis of RNA and proteins (including heat shock proteins), with a
focus on the apoptosis-sensitive thymocyte subset and the most thymotoxic organotin
compound DBTC. Results showed that DBTC increased RNA synthesis, while inhibiting
protein and DNA synthesis. This increase in RNA synthesis occurred in small high-
density CD4+CD8+ thymocytes, which comprised cells showing high incidence of DNA
fragmentation. Moreover, co-exposure to the RNA synthesis inhibitor actinomycin D or
the protein synthesis inhibitor cycloheximide protected cells from apoptotic cell death by
DBTC or TBTC. Finally, organotin compounds were found to induce synthesis of the
heat shock protein HSC73. Heat shock treatment (42°C, 20 min) did not initiate apoptosis
in rat thymocytes, neither antagonized organotin-induced DNA fragmentation. Results
together indicate that organotin-induced apoptosis involves the synthesis of yet
unidentified RNA-molecules and proteins, and additionally, that the subset of thymocytes
that is subject to apoptosis by organotins, i.e. the CD4+CD8+ subset, differs from the one
(immature blastoid CD4-CD8+ and CD4+CD8+) that was previously characterized as
being sensitive to the anti-proliferative effects of organotins.
INTRODUCTION
Derivates of dialkyltin compounds, like di-n-butyltin dichloride (DBTC), are used in
various industrial applications such as PVC-stabilizers and catalyzers. Trialkyltin
compounds, like tri-n-butyltin chloride (TBTC), are used as biocides for instance in
agriculture, in anti-fouling paints and in fabrics (Fent, 1996). The toxicity of these
organotins towards the immune system is well known, with atrophy of the thymus cortex
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as the most obvious effect of both DBTC and TBTC (Seinen and Willems, 1976; Seinen
et al., 1977; Seinen et al., 1979; Krajnc et al., 1984; Snoeij et al., 1988). In a series of
studies we have shown that relative low doses (15-20 mg/kg body weight) of these
organotins selectively inhibit the proliferation of immature CD4-CD8+CD3-/low and
CD4+CD8+CD3-/low thymoblasts without signs of apoptotic cell death (Pieters et al., 1992;
Gennari et al., 1997, see also chapter 2). Others have shown that at higher doses of in
particular TBTO (tributyltin oxide) apoptosis was the predominating process leading to
thymocyte depletion (Aw et al., 1990; Raffray and Cohen, 1993a). A similar
concentration-dependent effect was observed in vitro. Low concentrations of either one
of these organotin compounds caused inhibition of DNA synthesis (Seinen et al., 1979;
Snoeij et al., 1986), whereas at higher concentrations these chemicals induced cell death
by apoptosis (Aw et al., 1990; Raffray and Cohen, 1993a). At even higher concentrations
necrosis was the prevailing mode of cell death (Raffray et al., 1993b; Gennari et al.,
1997, see also chapter 2).
The process of apoptotic cell death by TBTC in particular, has been studied in some
detail. It is shown that TBTC has a Ca2+ ionophoric effect that is claimed to trigger
endonuclease-dependent DNA fragmentation without the need of macromolecular
(protein and RNA) synthesis (Aw et al., 1990; Raffray et al., 1993b). Other studies
however, demonstrated that TBTC at concentrations known to cause apoptosis, also
stimulated RNA synthesis (Snoeij et al., 1986) and de novo synthesis of heat shock
proteins (HSPs) (Zhang and Liu, 1992). For DBTC no mechanistic information exists
regarding apoptosis, mainly because the capacity of this compound to induce apoptosis
was unnoticed until recently when this effect was reported to be time-dependent (Gennari
et al., 1997, see also chapter 2). Briefly, apoptosis by DBTC could not be detected after 1
h of incubation (Aw et al., 1990; Raffray and Cohen, 1993a), but after short-term
incubation followed by overnight culture or continuous exposure for 22 h DNA
fragmentation could be readily detected (Gennari et al., 1997, see also chapter 2).
The present study was performed to investigate the relation between organotin-induced
apoptosis and synthesis of RNA and proteins, in particular for DBTC since this
compound is regarded as the most effective thymotoxic organotin compound and
presumably the active metabolite of TBTC (Snoeij et al., 1988).
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MATERIALS AND METHODS
Chemicals and solutions
DBTC (Johnson Matthay Alfa Products, Karlsuhe, Germany), TBTC (gift from Dr. H.
Meinema, TNO, Zeist, The Netherlands), DEX (10 µM, Sigma, St. Louis, MO, USA) and
actinomycin D (Act D, 0.16 µM, Sigma) were dissolved in ethanol absolute (final ethanol
concentration 0.1%, which is ineffective by itself) and then diluted in RPMI.
Cycloheximide (CHX, 10 µM, Sigma) was dissolved in bidest. Propidium Iodide (PI,
Sigma) was dissolved in PBS to obtain a concentration of 5 µg/ml. Ribonuclease A
(RNase, type I-A, Sigma) was dissolved first in TRIS-buffer (10 mg/ml), boiled for 15
min, and then diluted in RNase buffer (0.1% sodium-citrate, 0.1% triton X-100) to obtain
a lysis buffer with a final concentration of 0.5 mg/ml RNase. RPMI-1640 (Gibco, Paisley,
U.K.) was used supplemented with 5% heat-inactivated fetal calf serum (Gibco), 1%
glutamine (Gibco), penicillin/streptomycin (Flow, Irvine, U.K.), sodium bicarbonate
(Gibco), 1% HEPES buffer (Gibco). PBS was supplemented with 4 mM Ca2+, 10 mM
Mg2+ and 2 mM glucose.
Tran 35S-label (ICN Biomedicals Inc., Irvin, USA), Hyperfilm B-max (Amersham, `s
Hertogenbosch, The Netherlands) and Immobilon-P membranes (Immobilon PVDF
Transfer, Millipore, Etten-Leur, The Netherlands), were used for metabolic labeling
experiments. Blots were stained with specific monoclonal antibody directed to HSP72
(clone N27F3-4, Stressgen, Victoria, Canada) and HSC73/HSP72 (clone C92F3A-5,
Stressgen). 3H-Methyl-Thymidine (3H-TdR), 3H-Uridine (3H-Urd), 14C-Leucine (14C-Leu)
and 35S-tran (containing 35S-methionine) were purchased from the Radiochemical Center,
Amersham, UK.
OX8 (anti-CD8)- and ER2 (anti-CD4)-producing hybridomas were cultured in-house
(OX-8 line obtained from European Collection of Animal Cell Cultures, Salisbury, U.K.
and ER2 from Dr. J. Rozing, University of Groningen, The Netherlands). Biotine
conjugated OX8 and ER2-FITC were used to detect CD4 vs. CD8 positivity of thymocyte
subsets. Streptavidin-phycoerythrine (Southern Biotechnology Association, SBA, Inc.,
Birmingham, USA) was used to visualize binding of OX8-biotine.
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Animals
Male rats, used at the age of 4-5 weeks, were bred and housed at the Animal Facilities
of the Utrecht University. They were kept in filter-top macrolon cages with ad libitum
food and acidified drinking water. Rats were killed by decapitation and thymi were
aseptically removed without adjacent parathymic lymph nodes.
Cell suspensions and culture
Thymocyte suspensions were prepared by crushing the thymus on a nylon sieve and
collecting the cells in ice-cold PBS. After centrifugation, cells were resuspended in RPMI
1640-supplemented, incubated for 10 min in a water bath (37°C) with the compounds,
washed twice, and then incubated overnight (22 h) at 37°C without compounds. DEX,
Act D and CHX were present throughout the whole incubation period of 22 h.
Centrifugal elutriation
Centrifugal elutriation of thymocytes was performed as described by Snoeij et al.
(1986), using a Beckman J2-21 centrifuge equipped with a JE-6B elutriator rotor. The
flow was generated by hydrostatic pressure. An amount of 3-5x108 cells was introduced
with a flow of 12 ml/min and a rotor speed of 3200 rpm. After 5 min of equilibration, the
first fraction was obtained by increasing the flow to 18 ml/min. Then, 6 additional
fractions were collected by stepwise decreasing the rotor speed to 3000, 2900, 2800,
2600, 2200 and 2000 rpm. All fractions were obtained in volumes of 50 ml. After
sedimentation at 200 g for 10 min, fractions collected at 3200, 3000 and 2900 rpm were
pooled as small-sized cells, at 2800 and 2600 rpm as middle-sized cells and at 2200 and
2000 rpm as large-sized cells.
DNA, RNA and protein synthesis detection
The effect of DBTC on DNA, RNA and protein synthesis was estimated by
determination of the incorporation rate of 3H-TdR, 3H-Urd, 14C-Leu into acid-precipitable
material. After a 30 min pre-incubation period with graded concentrations of organotin
compounds, 1 µCi/ml 3H-TdR (final concentration 20 nM), 1 µCi/ml 3H-Urd (final
concentration 20 nM) or 50 nCi/ml 14C-Leu (final concentration 145 µM) was added to
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rat thymocyte suspensions (2x107 cells/ml). At regular intervals up to 60 min after
addition of the label, samples were taken in 4-fold and cells were harvested onto glass
fiber filters using a 5%-solution of trichloroacetic acid. Radioactivity was counted in a
Kontron MR 300 liquid scintillation counter.
Induction of heat shock response
Cells resuspended in RPMI 1640-supplemented, were incubated at 42°C for 20 min in a
water bath and then incubated at 37°C overnight. In case of cells treated with compounds,
after heat shock induction, thymocytes were incubated 10 min with DBTC or TBTC,
washed twice and then incubated at 37°C overnight without compounds.
HSP detection
Suspensions of thymocytes were prepared as described above, and cells were exposed to
graded concentrations of the test compounds in 96 well plates, 106 cells per well in RPMI
without methionine or serum. Following pre-incubation with chemicals for 30 min at
37°C, 35S-tran was added to a final activity of 25 µCi/ml and cells were labeled for 2 h in
the continuous presence of compounds. Control and heat-shock samples were incubated
in test vials. After labeling, cells were washed three times in ice-cold phosphate-buffered
saline (PBS), and lysed in 50 µl Laemmli sample buffer. Aliquots of the samples were
harvested on glassfiber filters and incorporated radioactivity was measured to determine
total protein synthesis.
Samples were then run on 10% SDS-polyacrylamide slab gels in a discontinuous buffer
system. Separated proteins were blotted onto a membrane that was used for autoradio-
graphy and/or immunoblotting. Autoradiograms were obtained from radiolabeled proteins
on the blots by direct exposure of films at room temperature for 2-7 days. For further
characterization of heat shock proteins, membranes were blocked with Tris-buffered
saline/1% milk powder for 1 h and then incubated with a mixture of the two anti-HSP
antibodies for another hour. Thereafter, membranes were washed three times with
TBS/0.05% Tween 20 (TBS/T) and incubated with the appropriate dilutions of
appropriate alkaline phosphate conjugated second step antibody for another hour (goat-
anti-mouse-IgG-AP, Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD, USA;
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anti-rat-IgG-AP, Sigma Chemical Company, St. Louis, MO, USA; anti-rabbit-IgG-AP,
Boerhinger Mannheim GmbH Biochemica, Mannheim, Germany). After three more
washes in TBS/T, bands were developed by incubation with 5-bromo-4-chloro-3-indolyl
phosphate and nitroblue tetrazolium in Tris buffer, pH 9.5 (20 min).
Detection of apoptosis
Detection of DNA fragmentation by flow cytometry with PI as fluorescent indicator was
done essentially as described by Nicoletti et al. (1991). Briefly, after incubation with the
test compounds, 5x106 cells/ml were centrifuged and resuspended in 1 ml PBS; then
200 µl of this cell suspension was incubated with 0.5 ml RNase-containing lysis buffer
for 30 min at room temperature. Thereafter, 0.5 ml PI (5 µg/ml) was added and the
fluorescence of individual nuclei was measured (in the FL2 channel set for log scale)
using a FACScan flow cytometer (Becton-Dickinson, Erembodegem, Belgium).
A second method was used to characterize the thymocyte subset affected by organotin-
mediated apoptosis. This protocol, described by Swat et al. (1991), uses forward scatter
(FSC)/side scatter (SSC) and CD4/CD8 expression as characteristics for apoptotic cells
(apoptotic thymocytes have a low FSC and a high SSC and low expressions of CD4 and
CD8). Briefly, thymocytes were incubated in PBS/1% (w/v) BSA with optimal dilutions
of OX8-biot and ER2-FITC for 30 min, washed and stained for 30 min with streptavidin-
phycoerythrin. After a final washing, FSC/SSC and CD4/CD8 staining patterns were
analysed on a FACScan flow cytometer (Becton Dickinson, Erembodegem, Belgium,
equipped with a single argon laser).
Statistics
Statistical significance was determined by Student's t-test or Dunnett's multiple
comparison test after analysis of variance.
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RESULTS
DBTC increases the synthesis of RNA in small thymocytes
Previously, TBTC was shown to increase the synthesis of RNA in rat thymocytes. Here,
we demonstrate that also DBTC is able to do so (fig. 1). After an incubation period of 30
min, RNA synthesis increased in a concentration-dependent manner up to an optimum at
a concentration of 5 µM DBTC. At 10 µM RNA synthesis remained at control level. The
inhibitory EC50s for DNA and constitutive protein synthesis for DBTC in these studies
were of 3.0 and 0.6 µM, respectively (fig. 1).
Because it was known that DBTC had a profound anti-proliferative effect on large-sized
thymocytes in vivo (Snoeij et al., 1988; Pieters et al., 1992; 1994), we next studied
whether the effects of this organotin compound on the synthesis of RNA were confined to
a same subset of thymocytes. Fig. 2 illustrates however, that the smallest cells (diameter
between 4.3 µM and 6.8 µM) show a dose-dependent increase in the synthesis of RNA,
reaching 447% of control level at 5 µM of DBTC. RNA synthesis was unaffected in
middle-sized (6.8 µM to 8.6 µM) and large-sized thymocytes (over 8.6 µM).
Fig. 1. Effects of DBTC on 3H-Urd, 3H-TdR and 14C-Leu incorporation in rat thymocytes, after an
incubation period of 30 min. The organotin compound was used at concentrations from 0.1 µM up to 10
µM. The maximum increase of RNA synthesis is obtained at 5 µM DBTC, whereas the half-maximal
inhibition for DNA and protein synthesis occurs at 3 and 0.6 µM DBTC, respectively. Values represent one
typical experiment.
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Fig. 2. Effects of DBTC on 3H-Uridine incorporation on subsets of thymocytes: small (diameter between
4.3 µM and 6.8 µM), middle (diameter between 6.8 µM and 8.6 µM) and large cells (diameter above 8.6
µM). Increase of uridine incorporation is DBTC-concentration-dependent. Values are means ± SD of three
separate experiments.
Organotin-induced apoptosis occurs in the CD4+CD8+ subset
It is well known that the majority of small thymocytes belongs to the CD4+CD8+ subset.
Therefore, we used the method of Swat et al. (1991) to detect apoptosis in thymocytes as
this method enables characterization of apoptosis in CD4+CD8+ thymocytes. We
observed that after 10 min exposure, followed by overnight culture without compounds,
both DBTC (1 µM and 5 µM, fig. 3) and TBTC (not shown) caused a shift of normal
viable thymocytes (normal FSC, and normal or low SSC, corresponding with
CD4highCD8high thymocytes) to cells with a lower FSC and a higher SSC (corresponding
with CD4lowCD8low thymocytes). The simultaneous shift of the percentage of
CD4highCD8high thymocytes in favour of CD4lowCD8low thymocytes indicates that
organotin-induced apoptosis takes place in CD4+CD8+ thymocytes.
Inhibition of RNA and protein synthesis decreases organotin-induced apoptosis
From the above results we argued that the increased synthesis of RNA was linked to the
induction of apoptosis. Therefore, we incubated rat thymocytes with combinations of
organotins and the classical RNA synthesis inhibitor Act D. In addition, because
apoptosis in many cases is protein synthesis-dependent, we also examined whether the
protein synthesis inhibitor CHX was able to inhibit organotin-induced apoptosis. In fig. 4
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it is shown that both inhibitors are able to decrease the fragmentation of DNA induced by
DBTC (1 µM) or TBTC (1 µM) after 10 min exposure, followed by overnight culture
without organotins but still in presence of the inhibitors. For Act D however, the decrease
of apoptosis appeared more effective in case of DBTC (27%) than in case of TBTC
(15%), whereas CHX inhibited TBTC- and DBTC-induced apoptosis to the same extent.
These inhibitors by themselves did not induce DNA fragmentation and, like expected,
they inhibited DEX-induced apoptosis.
Fig. 3. Induction of apoptosis by DBTC (10 min, then overnight culture without compound) in thymocytes,
analysed by FACS. Upper panels show cell-size (FSC) vs. cell density (SSC) and lower panels show CD4
vs. CD8 staining. Gate 1 is set for viable thymocytes (normal FSC and SSC) and corresponds with
CD4highCD8high thymocytes and gate 2 is set for SSChighFSClow cells, corresponding to apoptotic
CD4lowCD8low thymocytes.
DBTC and TBTC stimulate synthesis of the heat shock protein HSC73
Because the organotins used in this study are effective inhibitors of protein synthesis by
themselves, the protective effect of CHX was somewhat surprising. Apparently, some
proteins are still synthesized or even up-regulated under the influence of organotins.
Analyses of de novo protein synthesis in the presence of DBTC or TBTC revealed the
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appearance of HSC73 (fig 5A). Other HSPs, as observed in case of heat shock treatment,
were not detected. The classical protein inhibitor CHX was also found to induce proteins
between 38 and 56 KDa, but not HSC73 (fig 5B). Although we used 35S-methionin as
protein precursor in this series of experiments, the EC50 value was the same as with 14C-
Leu as precursor (data not shown), and importantly, in all cases HSP was detected only
when the inhibition of the protein synthesis was over 20%.
Fig. 4. DNA fragmentation measured by propidium iodide method on flowcytometer in thymocytes treated
with DBTC (1µM), TBTC (1 µM) or DEX (10 µM) in combination with the RNA synthesis inhibitor Act D
(0.16 µM) and the protein synthesis inhibitor CHX (10 µM). Values are means ± SD of three separate
experiments. $ p<0.05, compared to EtOH (negative control), # p<0.05, compared to DEX (positive
control), * p<0.05, compared to organotin compounds.
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Fig. 5. SDS-polyacrylamide gel electrophoresis of proteins extracted from thymocytes incubated with
increasing concentrations of DBTC or TBTC (from 0 to 1µM) (A) or with the protein synthesis inhibitor
CHX (B). Cells treated for 2.5 hrs with organotin compounds showed induction of HSC73, whereas CHX
induced synthesis of various proteins in the range of 38-56 KDa, but not of HSC73.
co
ntr
ol
he
at
sh
oc
k 0 0.1 0.3 1.0
DBTC
0 0.01 0.1 0.3
TBTC
kDa
56
70
88
120
HSP
HSP90
HSC73
HSP72
HSP60
A
co
ntr
ol
he
at
sh
oc
k 0 0.1 0.3 0.5 1.0 3.0
CHX
kDa
56
70
88
120
HSP
HSP90
HSP73
HSP72
HSP60
B
Chapter 3
53
Fig. 6. Quantitative analysis of apoptosis by flow cytometry in thymocytes treated with EtOH (negative
control), DEX (10 µM, positive control) or HS (42°C for 20 min). The amount of apoptotic nuclei is
indicated as percentage. Values are means ± SD of three separate experiments.
Heat shock does not antagonize initiation of apoptosis induced by organotins
Others (Migliorati et al., 1992) have shown that HSPs induced by heat shock (42°C, 20
min) are able to protect mouse thymocytes from glucocorticosteroid-induced apoptosis,
whereas on the other hand HSPs by themselves initiate apoptosis. However, in rat
thymocytes, heat shock treatment appeared unable to induce apoptosis (fig. 6) and in
addition did not protect rat thymocytes from organotin- nor glucocorticosteroid
(dexamethasone)-induced apoptosis (fig. 7).
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Fig. 7. Flow cytometry of PI-stained nuclei of thymocytes treated with HS (42°C for 20 min) alone or with
HS in combination with 1 µM DBTC or TBTC. Values are means ± SD of three separate experiments.
DISCUSSION
Results described in this chapter show that the thymotoxic organotin compound DBTC
increases the synthesis of RNA in a concentration-dependent manner, but most clearly at
relative high concentrations (an optimum of synthesis is obtained at 5 µM DBTC). Like
demonstrated before in case of TBTC (Snoeij et al., 1986), the increase of RNA occurs in
small-sized, high-density thymocytes. Previously, we have found that both TBTC and
DBTC were able to cause apoptosis in rat thymocytes in a time- and concentration-
dependent manner (Snoeij et al., 1988). Now, we show that organotin-induced apoptosis
seems to affect CD4+CD8+ thymocytes in particular, and that the process of DNA
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fragmentation is RNA- and protein-synthesis-dependent. It is worthy to note that
thymocyte selection takes place in small CD4+CD8+ thymocytes and that they are
vulnerable to initiators of apoptosis (Swat et al., 1991). Apparently, organotin compounds
enhance apoptosis in vitro in a subset of thymocytes that is different from the blastoid and
proliferating immature CD4-CD8+TcRαβ-/low or CD4+CD8+TcRαβ-/low subsets. The latter
two subsets are suggested to be the primary intrathymic targets in vivo in case of
relatively low doses of organotins (Pieters et al., 1992; 1994). This does not exclude,
however, the possibility that apoptosis occurs in these CD4+CD8+ thymocytes when
higher doses of organotins are used (Gennari et al., 1997, see also chapter 2).
The present data on the importance of protein are in contradiction with previous data by
Raffray et al. (1993b). They showed that pre-incubation with CHX had no effect on the
induction of apoptosis by tributyltin oxide (TBTO). However, the observed inhibitory
effects in the present study occur during overnight incubation of the cells with CHX,
whereas these previous studies used short-term (10 min) pre-exposures with the
inhibitors. Together, the role of de novo synthesis of proteins remains unclear, certainly
considering the potent protein inhibiting effects of these thymotoxic organotins.
Both organotin compounds initiate HSC73 synthesis at concentrations that inhibit
protein synthesis to around 20% of control. Previously, Migliorati et al. (1992), showed
that heat shock (HS) was able to induce apoptosis in mouse thymocytes and moreover to
protect cells from glucocorticoid-induced cell death. Present data show that HS in rat
thymocytes is not capable to significantly increase DNA fragmentation, or to inhibit
organotin- or DEX-mediated apoptosis. The observed difference may be due to species-
specifity.
Because CHX, which does not induce apoptosis in thymocytes, also induces synthesis
of HSPs, although a different pattern, it can be argued that induction of HSC73 by DBTC
or TBTC is not due to a specific, direct effect of organotin compounds, but rather a
consequence of suppression of protein synthesis (Albers et al., 1996). So, although HSPs
are not likely to be involved in the initiation phase of apoptosis, some (other) newly
synthesized but yet undefined proteins seem to be required in particular possibly at late
steps of organotin-induced apoptosis.
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Future studies will address the characteristics of the proteins and the RNA molecules
that are produced. This would enable mechanistic linkage between the present effects
with the known capacity of the organotins to affect a variety of cellular and biochemical
processes, including interference with ATP level (Snoeij et al., 1986; Marinovich et al.,
1990), increase of Ca2+ influx (Chow et al., 1992), interaction with T cell receptor
signalling (Pieters et al., 1995), cytoskeleton-activity (Chow et al., 1994), and
mitochondrial activity (Corsini et al., 1997).
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ABSTRACT
The thymotoxic organotin compounds, as di-n-butyltin dichloride (DBTC) and tri-n-
butytin chloride (TBTC) are known to induce apoptosis in vitro in rat thymocytes. They
also affect macromolecular synthesis, inhibiting DNA synthesis and increasing RNA
synthesis. Since these RNA molecules, likely to be involved in the initiation of the
apoptotic process, have not been identified yet, the purpose of this research was to
characterize, by a cDNA macro array, the expression of genes involved in apoptosis.
Results showed that two genes, namely glutathione-S transferase (GST), and nur77 were
rapidly transcripted following exposure of rat thymocytes to 3 µM DBTC. The products of
both genes are known to be involved in the apoptotic process: GST is a defense enzyme
aimed to cellular detoxification, while nur77 is a transcription factor expressed in response
to TCR mediated apoptosis in immature T cells.
Antisense oligonucleotide inhibition of nur77 expression prevented apoptosis induced by
DBTC, supporting a role of nur77 in organotin-induced apoptotic cell death.
INTRODUCTION
Di- and tri-substituted organotin compounds are used in a variety of technical
applications. Dialkyltin compounds, such as di-n-butyltin dichloride (DBTC) are used
primarily as stabilizers for polyvinylchloride plastics, while the trisubstituted organotins,
such as tri-n-butyltinchloride (TBTC), are widely used as biocides for the preservation of
paper and wood, for disinfection of surfaces and cooling water, and as active ingredient in
antifouling paints (Van der Kerk, 1978; Fent, 1996).
Both DBTC and TBTC are known to induce a selective, dose-dependent reduction of
thymus weight and thymocyte number in rats (Seinen and Willems, 1976; Seinen et al.,
1977). In vitro, and possibly also in vivo at high doses, they induce apoptosis in rat
thymocytes (Aw et al., 1990; Raffray and Cohen, 1991; Gennari et al., 1997, see also
chapter 2). Dialkyltin and trialkyltin compounds are also potent metabolic inhibitors, and
strongly reduce oxidative phosphorylation processes and ATP synthesis in mitochondria
(Penninks et al., 1983; Snoeij et al., 1987). Mitochondria have also an important role in the
pathway leading the cell to DNA fragmentation, being a source of reactive oxygen species
(ROS) and of pro-apoptotic factors such as cytochrome c (McConkey et al., 1989; Stridh et
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al., 1998; Gennari et al., 2000b, see also chapter 5). Furthermore, DBTC and TBTC are
known to affect macromolecular synthesis, suppressing DNA and protein synthesis and
increasing RNA synthesis (Snoeij et al., 1986; Gennari et al., 2000a, see also chapter 3). In
freshly isolated rat thymocytes, the increase of RNA synthesis occurred in the small high-
density CD4+CD8+ subset, which comprised also of the cells sensitive to apoptosis after
organotin compounds exposure (Snoeij et al., 1987; Gennari et al., 2000a, see also chapter
3). Recent data showed that DNA fragmentation induced by organotins was RNA- and
protein-synthesis-dependent (Gennari et al., 2000a, see also chapter 3), which is in
agreement with the general idea that macromolecular synthesis is required for apoptosis. It
has been shown that organotins initiated the synthesis of the heat shock protein HSC73 at
concentrations that inhibited protein synthesis to around 20% of control. This induction of
HSC73, however, appeared not to be a specific, direct effect of organotin compounds, but
rather a consequence of suppression of protein synthesis (Gennari et al., 2000a, see also
chapter 3). So, other yet unknown neo-synthesized proteins seem to be required in
organotin-induced DNA fragmentation. The aim of this study was to identify newly
synthesized apoptosis-related RNA molecules induced by DBTC, and to characterize their
involvement in the apoptotic process.
For this purpose, we used a commercially available rat cDNA macro array that allows the
analysis of multiple genes simultaneously.
MATERIALS AND METHODS
Chemicals and solutions
Dibutyltin (DBTC) was obtained from Johnson Matthay Alfa Products (Karlsruhe,
Germany) and propidium iodide (5 µg/ml PI) from Sigma (St. Louis, MO). Ribonuclease A
(RNase, type I-A, Sigma) was dissolved first in Tris buffer (10 mg/ml) and boiled for
15 min and then diluted in RNase buffer (0.1% sodium citrate, 0.1% Triton X-100) to
obtain a final concentration of 0.5 mg/ml. RPMI 1640 (Sigma) was supplemented with 5%
heat-inactivated fetal calf serum (Sigma), penicillin (100 U/ml), and streptomycin (100
µg/ml).
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Animals
Four-five week old female Wistar rats (Charles River, Calco, Italy) were used for the
experiments. Animals were housed three to four per cage on woodchip bedding, and
allowed food and water ad libitum. Rats were killed with CO2 and thymi were isolated.
Cell suspensions and incubation
Cell suspensions from thymi were prepared as described by Gennari et al. (1997, see also
chapter 2). For the experiments, thymocytes were incubated with 3µM DBTC dissolved in
ethanol absolute (EtOH) or with EtOH as vehicle control (the final EtOH concentration
was 0.1%, ineffective by itself).
Apoptosis rat cDNA expression-array
The identification of cDNAs has been performed using the ″apoptosis rat cDNA
expression macro-array kit″ (Clontech, Palo Alto, CA). Briefly, after 30 min of incubation
with 0 or 3 µM DBTC, RNA was extracted from thymocytes as described by Chomczynski
and Sacchi (1987) and 250 µg of total RNA was treated with DNase. After assessing yield
and purity, 2 µg of RNA were used to be converted into α-
32
P-labeled first strand cDNA
and then hybridized to the Atlas Array membranes following instructions. After exposure
of the membrane to x-ray film (Kodak X-OMAT) at -80°C dark spots, representing
cDNAs, were identified following Clontech template.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RT-PCR reactions were performed as previously described (Corsini et al., 1996) with
slight modifications, in order to confirm the induced genes. Briefly, 2 µg of total RNA was
resuspended in a 11.5 µl final volume of deionized H2O and then 1 µl of oligod(T) (Perkin
Elmer, Norwalk, CT) was added to each sample. After the samples reached 70°C for
10 min, the reaction mixture [0.1 M dithiothreitol (Gibco, Grand Island, NY), 10 mM
dNTPmix (Perkin Elmer), First Strand Buffer (Gibco), Superscript reverse transcriptase
(Gibco)] was added and tubes were incubated for 30 min at 42°C and for 15 min at 70°C.
PCR primers for rat nur77, glutathione S-transferase (GST) and glyceraldehyde 3-
phosphate dehydrogenase (GPDH, housekeeping gene) were synthesized by Primm (Milan,
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Italy) and contained the following sequences: rat nur77 sense: 5’-TTCCACCGAACTGC-
AGCATC-3’; antisense: 5’-TACCCGAAGGGCCCGGACGT-3’; rat GST sense: 5’-TCG-
CTCGGAACTTC GGTCTG-3’; antisense 5’-ACCAGGTGGTTCAGGACCGG-3’;
mGPDH sense: 5’-CATGTAGGCCATGAGGTCCACCAC-3’; antisense 5’-TGAAGGT-
CGGTGTGAACGGATTTGGC-3’. Five-microliter aliquots of the synthesized cDNA (200
ng RNA) were added to a mixture containing 2.5 µl PCR buffer (Perkin Elmer), 2 µl
dNTPmix, 0.25 µl of specific primers, 0.25 µl Taq (Perkin Elmer), 1.88 µl MgCl2.
Amplifications were initiated with 6 min of denaturation at 95°C for 1 cycle, followed by
35 cycles at 95°C for 1 min, 57°C for 1 min, and 72°C for 1 min. After the last cycle of
amplification, the samples were incubated for 10 min at 72°C.
The PCR products were visualized by UV illumination following electrophoresis through
2% agarose at 80 V for 1 h and staining in Tris-borate-EDTA (TBE) containing 0.5 µg/ml
ethidium bromide. The amplified PCR products from total RNA were 478 bp for nur77,
389 bp for GST and 983 bp for GPDH. Gels were photographed with type 667 film
(Polaroid, Cambridge, MA).
Preparation of nuclear extracts and electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared essentially as described by Schreiber et al. (1989). After
10 min treatment with 0 or 3 µM DBTC, followed by 30 min incubation at 37°C without
compounds, rat thymocytes were washed once and resuspendend in 1 ml of a hypotonic
lysis buffer (buffer A: 10 mM Hepes, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM
dithiothreitol [DTT], 0.5 mM phenylmethylsulfonyl fluoride [PMSF]). Cells were
incubated for 15 min, then 62.5 µl of a 10% Nonidet P-40 (Sigma) solution was added, and
after 30 seconds of mixing they were centrifuged. The pelleted nuclei were washed once
with 200 µl of buffer A plus 12.5 µl of 10% Nonidet P-40, centrifuged, suspended in 50 µl
buffer C (20 mM Hepes, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM
PMSF), mixed for 20 min, and then centrifuged. The supernatant containing nuclear
proteins was harvested and protein concentration was determined (Bio-Rad Protein Assay).
Electrophoretic mobility shift was performed as follows. Binding reaction mixtures (16 µl)
containing 4 µg of nuclear extract, 2 µg poly dI-dC, 10.000 cpm 32-P-labeled probe, 8 µl
buffer D (10 mM Hepes, 2% Ficoll, 100 mM NaCl, 2 mM EDTA, 20% glycerol, 0.4 µg/ml
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albumin, 2 mM DTT) were incubated for 30 min at room temperature before separation in
a 5% acrylamide gel in TBE followed by autoradiography. A double-strand oligonucleo-
tide containing the binding site for nur77 (5’-GGAGTTTTAAAAGGTCATGCTCAAT-
TT-3’, Primm) was labeled with [α-32P]dATP (Amersham, Buckinghamshire, UK) using
T4 polynucleotide kinase (Amersham).
Antisense oligonucleotide treatment and detection of apoptosis
The sense (5’-ATGGGTCCTCGCCTCAAGGAG-3’) and antisense (5’-CTCCTTGAGG-
CGAGGACCCAT-3’) phosphorothioate analogues of the oligonucleotides to the 5’-end of
nur77 mRNA were synthesized and obtained from Primm. Cells were preincubated for 30
min with oligonucleotides, followed by 10 min DBTC exposure and then overnight
incubation with oligonucleotides without DBTC.
Detection of apoptosis by flow cytometry with PI as fluorescent indicator was done
essentially as described by Nicoletti et al. (1991). Briefly, after incubation with the test
compounds, 5x106 cell/ml were centrifuged and resuspended in 1 ml PBS. Of this
suspension 200 µl was incubated for 30 min with 0.5 ml RNase (0.5 mg/ml) at room
temperature. Then, 0.5 ml PI was added (5 µg/ml, in PBS) and the fluorescence of
individual nuclei was measured (in the FL2 channel set for log scale) on a FACScan flow
cytometry (Becton-Dickinson).
Statistics
Statistical analysis was determined by Student’s t-test. Each experiment was performed at
least three times, with representative results shown.
RESULTS
DBTC activates the synthesis of genes involved in apoptosis
It has been shown previously that DBTC induced synthesis of RNA (Gennari et al.,
2000a, see also chapter 3), but the characteristics of the RNA molecules that are produced
remained undefined. RNA extracted from freshly isolated rat thymocytes treated with 3
µM DBTC, was reverse transcribed to cDNA and then, using a rat cDNA macro-array kit,
hybridized to membranes. Fig. 1 shows the spots visible after exposure of the cells to EtOH
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(vehicle control) or to DBTC. As indicated by arrows, in case of organotin-treatment two
genes are found to be transcribed, which correspond to nur77 and glutathione-S transferase
(GST).
Fig. 1. Atlas rat cDNA expression array membranes. 32P-labeled probes were prepared from 2 µg of total
RNA, isolated from rat thymocytes treated for 30 min with EtOH as control (A) or with 3 µM DBTC (B).
New genes expression induced by DBTC is indicated with arrows.
EtOH
DBTC
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To confirm the synthesis of these genes, a RT-PCR has been performed. Clearly, gels in
fig. 2 indicate a time-related production of both nur77 (A) and GST (B) by DBTC.
Fig. 2. RT-PCR confirmed the expression of nur77 and GST. Gels show nur77 (A), GST (B) and GPDH
(C) amplification products from rat thymocytes treated with 3 µM DBTC for 15, 30 or 60 min or with
EtOH as control.
Increase of nur77 nuclear proteins by DBTC
A clear increase of the nur77 nuclear proteins is shown by the EMSA (fig. 3). After 10
min exposure of thymocytes to 3 µM DBTC, followed by 30 min of incubation without
compound, a significant activation of nur77 is present in DBTC-treated cells, compared to
controls.
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30 min
DBTC
60 min
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Inhibition of DBTC-induced apoptosis after antisense oligonucleotide treatment
To test whether the presence of nur77 was linked to organotin-induced DNA-
fragmentation, we blocked the transcription of nur77 with pretreatment of thymocytes with
antisense oligonucleotide followed by 10 min exposure to DBTC, and then by overnight
incubation in presence of oligonucleotide. Detection of apoptosis by flow cytometry
revealed that the percentage of apoptotic nuclei significantly decreased when activation of
nur77 was inhibited (fig. 4), indicating for the first time an important role of nur77 in
DBTC-induced apoptosis.
Fig. 3. DBTC induced nur77 activation.
Four µg of nuclear extracts were analysed
by electrophoretic mobility shift assay
(EMSA), with a 32P-labeled DNA probe
detecting the expression of nur77.
DISCUSSION
Previously, it has been shown that the organotin compound DBTC stimulates the
synthesis of RNA and heat shock protein (HSP) in rat thymocytes. RNA synthesis occurred
especially in the small high-density CD4+CD8+ subset, and this population was found to be
also the one vulnerable to induction of apoptosis by DBTC and TBTC (Gennari et al.,
nur77
EtOH DBTC
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2000a, see also chapter 3). Although recent data demonstrated that organotin-induced
apoptosis requires de novo gene expression (Gennari et al., 2000a, see also chapter 3),
nothing is known about the molecular pathways that mediate this response.
Fig. 4. DBTC-induced apoptosis can be reduced by nur77 antisense oligonucleotides. Cells were treated as
described in Materials and Methods. Values are means ± SD of three separate experiments. **p <0.01 vs.
control treated cells; ##p <0.01 vs. DBTC treated cells.
In order to characterize newly activated genes that are translated after short exposure of
thymocytes to DBTC, we first used the macro array cDNA kit, and then different
techniques to confirm the obtained data. Two genes, glutathione S-transferase (GST) and
nur77 have been identified, and both of them are known to be involved in the apoptotic
process by various stimuli (Flomerfelt et al., 1993; Winoto, 1994).
GST is an antioxidant defense enzyme involved in cellular detoxification (Mannervik and
Danielson, 1988) and it appeared to be regulated by reactive oxygen species (ROS)
activation (Rushmore et al., 1991). During apoptosis, an increase of ROS production
induces an increase of GST-levels. Thus, GST activation is a clear sign of cellular
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oxidative stress, rather then a necessary step in the apoptotic pathway (Flomerfelt et al.,
1993).
Nur77 is a member of the steroid/thyroid hormone receptor superfamily, which encodes a
number of ligand-dependent transcription factors. It has been shown to be expressed in
TCR-mediated DNA fragmentation (Liu et al., 1994; Winoto, 1994).
In contrast to GST, nur77 is considered to be a required transcription factor for the
initiation of apoptosis (Liu et al., 1994; Winoto, 1994). Indeed, our findings showed that
rat thymocytes treated with antisense oligonucleotides, which block the transcription of
nur77, significantly reduced DBTC-induced apoptotic nuclei compared to cells treated
only with the organotin compound. These data clearly indicate that DBTC requires the
synthesis of nur77 to initiate the apoptotic process. Although not much is known about the
targets of nur77, it is interesting to note that the glucocorticoid receptor (GR) activity
antagonizes nur77-dependent transcription (Philips et al., 1997). Since it has been found
that glucocorticosteroids antagonize organotin-induced apoptosis (Zucker et al., 1994), it
can be speculated that this effect is due to the repression of nur77 by glucocorticosteroids.
Furthermore, previous findings demonstrated that transcription of nur77 is regulated by
calcium signals (Woronicz et al., 1995). This is in accordance with our earlier results
(Gennari et al., 2000b, see also chapter 5), showing the increase of intracellular calcium
levels as an initial step in organotin-induced apoptosis.
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ABSTRACT
Di-n-butyltin dichloride (DBTC) and tri-n-butyltin chloride (TBTC) cause thymus
atrophy in rodents. At low doses, anti-proliferative modes of action have been shown to
be involved, whereas at higher doses apoptosis seems to be the mechanism of
thymotoxicity by these chemicals. In vitro, a similar concentration-dependency has been
observed. The purpose of the present research was to investigate the mechanisms
underlying DNA fragmentation induced by these organotin compounds in freshly isolated
rat thymocytes. As previously shown for TBTC, also DBTC is able to significantly
increase intracellular Ca2+ level ([Ca2+]i). The rise in [Ca2+]i, already evident 5 min after
treatment, was followed by a dose- and time-dependent generation of reactive oxygen
species (ROS) at the mitochondrial level. Simultaneously, organotins induced release of
cytochrome c from the mitochondrial membrane into the cytosol. ROS production and
release of cytochrome c were reduced by BAPTA, an intracellular Ca2+ chelator, or
rotenone, an inhibitor of the electron entry from complex I to ubiquinone, indicating the
important role of Ca2+ and mitochondria during these early intracellular events.
Furthermore, we demonstrated that rotenone prevents apoptosis induced by 3 µM DBTC
or TBTC, and in addition that both BAPTA and Z-DEVD FMK (mainly a caspase-3
inhibitor) decreased apoptosis by DBTC (already shown for TBTC).
Taken together these data show that the apoptotic pathway followed by organotin
compounds starts with an increase of [Ca2+]i, then continues with release of ROS and
cytochrome c from mitochondria, activation of caspases, and finally results in DNA
fragmentation.
INTRODUCTION
Dialkyltin compounds, such as di-n-butyltin chloride (DBTC), are industrially applied
as heat stabilizers in PVC plastics, and trialkyltin compounds, such as tri-n-butyltin
chloride (TBTC), are mainly used as biocides in crop protection and antifouling paints for
large ships (Fent, 1996).
In rats, organotin compounds reduce cortical thymocyte number and consequently
thymus weight (Seinen and Willems, 1976), and after prolonged exposure suppress T-
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cell-mediated immune responses (Seinen and Willems, 1976; Seinen et al., 1977). Low
doses of both DBTC and TBTC inhibit immature thymocyte proliferation, whereas high
doses of TBTC cause a depletion of thymocytes by apoptosis (Raffray and Cohen, 1993).
Previous kinetic studies have indicated that TBTC is dealkylated to DBTC, and that
DBTC is the toxicologically active compound (Snoeij et al., 1988).
In vitro, DBTC and TBTC are cytotoxic as well. At low concentrations, they effectively
inhibit DNA synthesis (Seinen et al., 1979; Snoeij et al., 1986), affect macromolecular
synthesis (Snoeij et al., 1986; Gennari et al., 2000, see also chapter 3), and disrupt
mitochondrial energy metabolism (Cain et al., 1977; Snoeij et al., 1986). At higher
concentrations (1-5 µM) these compounds are known to induce apoptosis (Aw et al.,
1990; Raffray and Cohen, 1991; Gennari et al., 1997, see also chapter 2).
The mechanistic studies have already linked a TBTC-induced sustained increase in the
cytosolic free Ca2+ concentration to a subsequent endonuclease activation and DNA
fragmentation (McConkey et al., 1989; Chow et al., 1992). On the contrary, due to the
previously unnoticed potential of DBTC to induce apoptosis, no mechanistic information
exists about the apoptotic process elicited by this chemical.
Many of the chemical and physical treatments capable of inducing apoptosis are also
associated with oxidative stress, suggesting an active role for reactive oxygen species
(ROS) in cell death (Buttke and Sandstrom, 1994). An important intracellular source of
ROS are mitochondria. Tri-organotin compounds are well known to disturb mito-
chondrial activity inhibiting ATP synthesis (Snoeij et al., 1987; Marinovich et al., 1990),
and it has been suggested that also DBTC could affect oxidative phosphorylation of
mitochondria in a similar way (Cain et al., 1977; Penninks et al., 1983). Corsini et al.
(1996; 1998) demonstrated that alterations of Ca2+ homeostasis precede TBTC-induced
ROS production at the mitochondrial level in murine keratinocytes.
Furthermore, targeting of mitochondria by TBTC has been shown capable of releasing
pro-apoptotic factors, such as cytochrome c, which is considered a primary event in the
induction of DNA fragmentation (Liu et al., 1996; Kroemer, 1997). TBTC induced
release of cytochrome c from the mitochondrial intermembrane space into the cytosol in
Jurkat cells and subsequently activated caspases, which cleave target proteins leading to
the irreversible damage of the cell (Stridh et al., 1998).
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The aim of this chapter was to define in thymocytes the apoptotic pathway elicited by
organotin compounds. A particular interest has been given to DBTC, as for this
metabolite of TBTC information on the process of DNA fragmentation is lacking.
MATERIALS AND METHODS
Chemicals and solutions
Dibutyltin chloride (DBTC) was obtained from Johnson Matthay Alfa Products
(Karlsruhe, Germany), tributyltin chloride (TBTC) from Aldrich (Steinhein, Germany), 6-
carboxy-2’,7’-dichlorodihydrofluorescein diacetate di(acetomethyl ester) (DCFH) and 1,1-
bis(2-aminophenoxy)ethane-N,N,N,N’-tetraacetic acid (BAPTA) from Molecular Probes
(Eugene, OR). Fura-2/AM, rotenone, ruthenium red (RR) and propidium iodide (PI) were
purchased from Sigma (St. Louis, MO). Ribonuclease A (RNase, type I-A, Sigma) was
dissolved first in Tris buffer (10 mg/ml) and boiled for 15 min and then diluted in RNase
buffer (0.1% sodium citrate, 0.1% Triton X-100) to obtain a final concentration of 0.5
mg/ml. Hank’s balanced salt solution (HBSS) was obtained from Sigma and RPMI 1640
(Sigma) was supplemented with 5% fetal calf serum (Sigma), penicillin (100 U/ml), and
streptomycin (100 µg/ml). Krebs-Henseleit buffer contained 20 mM HEPES, 5.5 mM
glucose, 1.3 mM CaCl2, 1 mM MgSO4, 1 mM KH2PO4, 5 mM KCl, 119 mM NaCl, pH
7.4. Z-DEVD-FMK (mainly a caspase 3 inhibitor) was purchased from Calbiochem (La
Jolla, CA, USA) and dissolved in DMSO to obtain the final concentration of 20 µM.
Animals
Four–five weeks old female Wistar rats (Charles River, Calco, Italy) were used for the
experiments. Animals were housed three to four per cage over woodchip bedding, and
allowed food and water ad libitum. Rats were killed with CO2 and thymi were isolated.
Cell suspensions and incubation
Cell suspensions from thymi were prepared as described by Gennari et al. (1997, see also
chapter 2). Thymocytes were incubated with different concentrations of DBTC or TBTC
dissolved in ethanol absolute (EtOH), or with EtOH as vehicle control (the final EtOH
concentration was 0.1%, which is ineffective by itself).
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For measurement of intracellular Ca2+ and oxidative activity (see below) thymocytes
were incubated with different concentrations of DBTC or TBTC (0-5 µM). To calculate the
release of cytochrome c cells were treated with 3 µM of organotin compounds for 5 min.
To detect apoptosis thymocytes were treated with 3 µM of organotins for 10 min, then
washed and incubated overnight at 37°C without compounds.
When necessary cells were pre-treated 30 min with BAPTA (10 µM, in DMSO), 30 min
with RR (5 µM, in H2O), 1 h with rotenone (20 µM, in DMSO) or 30 min with Z-DEVD-
FMK (20 µM, in DMSO) before incubation with organotins.
Determination of Ca2+ level
Isolated rat thymocytes (2x107 cells/ml) were loaded with 4 µM Fura-2/AM in buffer A
(Krebs-Henseleit buffer supplemented with 2% BSA) for 30 min at room temperature.
Cells were then washed and resuspended in buffer A without Fura-2/AM for another 15
min, to allow complete hydrolysis of Fura-2/AM. Just before use, thymocytes (3x106 cells)
were washed with buffer B (Krebs-Henseleit buffer supplemented with 0.2% BSA) and
resuspended in the same buffer in a quartz cuvette, where organotins were added. The
Fura-2/AM ratio signal was measured in a Perkin Elmer LS 50 B double-wavelength
fluorometer and calibrated in terms of [Ca2+]i as described by Grynkievicz et al. (1985).
Oxidative activity
Thymocytes (5x106 cells/ml) were washed once with HBSS containing 2% BSA and
loaded with 10 µM DCFH (stained) or DMSO (unstained) for 1 h at 37°C. Then cells were
washed once in HBSS and oxidative activity was assessed as follows. Ten million cells in
quartz cuvettes containing 2 ml HBSS were treated with different concentrations of DBTC,
TBTC or EtOH as control. ROS production was measured as DCFH oxidation by the
intensity of the emission of 525 nm fluorescence excited by 503 nm (Perkin Elmer LS
50B), at time 0, 5, 10, 15 and 30 min following treatment in both stained and unstained
cells. Results are expressed as the change in fluorescence (in arbitrary units, AU)
calculated as
AU= [Istained – Iunstained] tx – [Istained – Iunstained] t0,
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where I represents the intensity of fluorescence.
When necessary, cells were treated during loading period with BAPTA, RR or rotenone.
Cytochrome c release
After treatment with organotins, and eventually with BAPTA or rotenone, thymocytes
(5x106 cells/ml) were washed once in 5 ml ice-cold phosphate buffered saline (PBS). Cells
were then centrifuged and the pellet was resuspended in 200 µl of ice-cold buffer A (20
mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM
dithiothreitol [DTT], and 0.1 mM phenylmethylsulfonyl fluoride [PMSF]), supplemented
with protease inhibitors (1:50 protease inhibitor cocktail, Sigma). After being kept on ice
for 15 min, cells were lysed by passing 15 times through a G22 needle. After centrifugation
in a microcentrifuge for 5 min at 4°C, the supernatants were further centrifuged at 4x10 4 g
for 30 min at 4°C in a table top ultracentrifuge.
Protein concentration was calculated using the Bio-Rad Protein Assay with albumin as
the standard.
Western blotting
Protein extracts (20 µg) were loaded onto a 18% SDS-polyacrylamide gel and electro-
phoresed at 120V, then transferred to PVDF membranes (NEN, Boston, MA) at 250 mA
for 1 h. Membranes were blocked in 5% non-fat dried milk and then incubated with a
rabbit anti-cytochrome c polyclonal IgG antibody (1:1000 diluted in 5% non-fat dried milk,
Santa Cruz Biotechnology, Santa Cruz, CA) overnight at 4°C, followed by incubation with
an anti-rabbit IgG alkaline phosphate (AP)-conjugate antibody (1:50000 diluted in 5% non-
fat dried milk, Sigma) for 1 h at room temperature, and visualized by CDP-star (NEN).
The Western Blot image was acquired with a Nikon CCD video camera module (Nikon,
Melville, NY). The optical density of the bands was calculated, and peak area of a given
band was analyzed by means of the Image 1.61 program for digital image processing
(Wayne Rasband, Research Service Branch, NIH, MD).
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Apoptosis detection
Detection of apoptosis by flow cytometry with PI as fluorescent indicator was done
essentially as described by Nicoletti et al. (1991). Briefly, after incubation with the test
compounds, 5x106 cells/ml were centrifuged and resuspended in 1 ml PBS. Of this
suspension 200 µl was incubated for 30 min with 0.5 ml RNase (0.5 mg/ml) at room
temperature. Then, 0.5 ml PI was added (5 µg/ml, in PBS) and the fluorescence of
individual nuclei was measured (in the FL2 channel set for log scale) on a FACScan flow
cytometry (Becton-Dickinson, Italy).
Statistics
Statistical analysis was determined by Student’s t test or Dunnet’s multiple comparison
test, after analysis of variance. Each experiment was performed at least three times, with
representative results shown.
RESULTS
DBTC increases the level of Ca2+
It has been previously shown (McConkey et al., 1989; Chow et al., 1992) that TBTC is
able to increase cytosolic free Ca2+ concentration, but not much is known about the
influence of DBTC on Ca2+ level. Freshly isolated rat thymocytes loaded with Fura-2/AM,
were incubated with increasing concentrations (0-5 µM) of DBTC, and then analyzed for
cytoplasmic Ca2+ concentration. As shown in fig. 1, after addition of DBTC was detectable
an immediate rise in [Ca2+]i, that reached a plateau level in 5 min for all the concentrations
tested. The plateau levels were plotted in the graphic, and clearly showed a dose-dependent
intracellular Ca2+ increase which was statistically significant from the concentration of
3 µM.
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Fig. 1. DBTC induces a dose-dependent increase in [Ca2+]i. Cells were loaded with fura-2/AM, then
incubated with increasing concentrations (0-5 µM) of DBTC and after 5 min [Ca2+]i was measured as
described in Materials and Methods. Each value represents mean ± SD of three experiments. Statistical
analysis was determined by Student’s t test.
Organotin compounds induce reactive oxygen species production
Because alterations in Ca2+ homeostasis may induce oxidative stress, we tested whether
organotin compounds may affect reactive oxygen species (ROS) generation. As shown in
fig. 2A, DBTC was able to induce ROS production in rat thymocytes in a time- and dose-
dependent manner. A significant increase of ROS was observed starting from 5 min of
treatment. Also TBTC induced a time- and dose-dependent production of ROS (fig. 2B),
and it was at least three times more potent then DBTC. Indeed significant increase in ROS
was observed from 3 µM DBTC, whereas TBTC induced already a significant ROS
production at 1 µM.
We then hypothesized that organotin-induced increase in [Ca2+]i preceded ROS
generation at the mitochondrial level. To assess the role of Ca2+ and mitochondria in
organotin-induced ROS release, cells were pre-treated with non-cytotoxic concentrations
of the intracellular Ca2+ chelator BAPTA, or with the mitochondrial electron transport
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chain-inhibitor rotenone. Both treatments significantly reduced DBTC- and TBTC-induced
production of ROS. At the concentration tested, BAPTA and rotenone reduced respectively
of 41% and 28% DBTC-induced ROS (fig. 3A), and of 68% and 87% TBTC-induced ROS
production (fig. 3B).
Fig. 2. DBTC (A) and TBTC (B) induce cellular oxidative activity. ROS generation was measured by
DCFH oxidation, as indicated in Materials and Methods. Graphics represent the mean ± SD of three
experiments. Statistical analysis was determined by Dunnett’s t test with *p < 0.05 and **p < 0.01 vs.
EtOH treated cells.
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To further confirm the link between [Ca2+]i and generation of ROS at mitochondria level,
thymocytes were pre-treated with ruthenium red (RR), an inhibitor of mitochondrial Ca2+
channels. Also in this case, the combination of RR with organotin compounds significantly
decreased the release of ROS of 50% for DBTC and 65% for TBTC (table 1), confirming
mitochondria as the primary source of organotin-induced ROS production.
Fig. 3. BAPTA and rotenone prevent ROS production in thymocytes treated with organotin compounds.
Cells were first treated for 30 min with 10 µM BAPTA, or for 1 h with 20 µM rotenone or with DMSO as
vehicle control, and then 3 µM DBTC (A) or 3 µM TBTC (B) were added. Oxidative activity was
measured 15 min after organotin treatment. The arbitrary units (AU) of fluorescence in the control group
was 7±1. Each value represents mean ± SD of three experiments. Statistical analysis was determined by
Dunnett’s t test with *p < 0.05, **p < 0.01 vs. cells treated with DBTC/TBTC and ## p < 0.01 vs. control
treated cells.
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Table 1- Ruthenium red (RR) prevents organotin-induced cellular oxidative activity.
Treatment Oxidative activity
(% of relative control)
DBTC 212 ± 3##
DBTC + RR 110 ± 2*
TBTC 312 ± 9##
TBTC + RR 175 ± 11#,*
Cells were pre-treated for 30 min with 5 µM RR and then for 15 min with 3 µM DBTC or 3 µM TBTC.
The arbitrary units (AU) of fluorescence in the control group was 13±1. Each value represents mean ±
SD of three experiments. Statistical analysis was determined by Dunnett’s t test with *p < 0.05 vs. cells
treated with DBTC/TBTC and #p < 0.05, ##p < 0.01 vs. control treated cells.
DBTC and TBTC induce cytochrome c release
It has been previously shown in Jurkat cells that TBTC induced a rapid loss of
mitochondrial membrane potential, which is associated with the release of cytochrome c,
important for subsequent apoptosis (Stridh et al., 1998). Here, we tested whether also
DBTC, as TBTC, induced the release of cytochrome c from the mitochondrial membrane
into the cytosol of rat thymocytes. Cells were treated with 3 µM DBTC or TBTC for 5 min.
As shown by Western blot analysis of cytosolic extracts (fig. 4), both compounds induced
the release of cytochrome c (12 kDa). Interestingly, the release of cytochrome c induced by
organotins could be modulated by pre-treating thymocytes with BAPTA or rotenone (fig.
4), indicating a role for Ca2+ and ROS in organotin-induced cytochrome c release. By
densitometric analysis, the decrease in DBTC-induced cytochrome c release by BAPTA or
rotenone was of 32% and 27% respectively, while in case of TBTC was of 52% and 55%
respectively.
Reduction of apoptosis induced by DBTC and TBTC in presence of inhibitors
To link the early intracellular events induced by organotin compounds with later
induction of apoptosis, thymocytes were pre-treated with BAPTA or rotenone and DNA
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fragmentation was assessed by flow cytometry. Relatively to DBTC, the addition of
BAPTA or rotenone inhibited DBTC-induced apoptosis (fig. 5), indicating the importance
of [Ca2+]i and mitochondria as events leading to cell death. For TBTC the protective role of
BAPTA has been already shown by others (Aw et al., 1990), but we found that TBTC-
induced apoptosis could also be prevented by rotenone (fig. 5), demonstrating the key role
of mitochondria in the apoptotic process.
We then used Z-DEVD FMK to inhibit caspase 3 activation, in order to characterize the
apoptotic pathway activated by DBTC. As shown in table 2, apoptosis induced by 3 µM
DBTC was down-regulated by 30 min pre-treatment of the cells with Z-DEVD FMK
(already shown for TBTC, Stridh et al., 1998).
Fig. 4. DBTC and TBTC induce a rapid cytochrome c release. The presence of cytochrome c (12 kDa) in
cytoplasmic extracts was measured by Western blot with an anti-cytochrome c antibody, as described in
Materials and Methods. Sample extracts were prepared from thymocytes treated with EtOH (control), 3 µM
DBTC (A) or 3 µM TBTC (B) for 5 min. BAPTA (10 µM, for 30 min) or rotenone (20 µM, for 1 h) pre-
treatment, followed by addition of 3 µM DBTC or TBTC for 5 min, was used to demonstrate the role of
Ca2+ and ROS in organotin-induced cytochrome c release.
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Fig. 5. Organotin-induced apoptosis could be modulated by BAPTA and rotenone treatment. Flow
cytometry (PI staining) was used to quantify apoptosis induced by 3 µM DBTC or 3 µM TBTC, as
described in Materials and Methods. The amount of apoptotic nuclei is indicated as percentage of relative
control. The percentage of apoptotic nuclei in the control group was 10±1%. Values are means ± SD of
three separate experiments. Statistical analysis was determined by Dunnett’s t test with *p <0.05 vs. cells
treated with DBTC; **p <0.01 vs. cells treated with DBTC; $$p <0.01 vs. cells treated with TBTC; ##p
<0.01 vs. control treated cells.
Table 2- Z-DEVD FMK reduces apoptosis induced by 3 µM DBTC.
Treatment Apoptosis
(% of relative control)
DBTC 560 ± 5##
DBTC + Z-DEVD FMK 380 ± 3##,*
Flow cytometry was used to quantitatively measure DNA fragmentation, as described in Materials and
Methods. The percentage of apoptotic nuclei in the control group was 10±1%. Values are means ± SD
of three separate experiments. Statistical analysis was determined by Student’s t test with *p < 0.05
vs. cells treated with DBTC and ##p < 0.01 vs. control treated cells.
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DISCUSSION
Here, we demonstrate the important role of [Ca2+]i and mitochondria during apoptosis
induced by DBTC and TBTC in rat thymocytes. Previously, it has been shown that one of
the early events in the apoptotic cell death induced by TBTC is the rise in intracellular Ca2+
concentration (Aw et al., 1990). We have found that also DBTC is able to increase the
[Ca2+]i, at concentrations greater than 1 µM.
Based on previous results (Corsini et al., 1996; 1998) obtained in murine keratinocytes,
we hypothesized that a disturbance of the Ca2+ homeostasis may initiate organotin-induced
oxidative stress in thymocytes as well. High cytoplasmic Ca2+ levels can cause an
increased mitochondrial Ca2+ uptake and disruption of mitochondrial Ca2+ equilibrium,
which results in ROS formation (Chacon and Acosta, 1991) due to stimulation of electron
flux along the electron transport chain. Indeed both DBTC and TBTC were able to induce
generation of ROS in a time- and dose-dependent manner. Important to note is that TBTC
was more potent than DBTC in increasing oxidative activity.
To correlate Ca2+ and mitochondria in ROS release, rat thymocytes were pre-treated with
the Ca2+ chelator BAPTA, the electron transport chain-inhibitor rotenone as well as with
RR, an inhibitor of mitochondrial Ca2+ channels. The presence of these inhibitors resulted
in a significant reduction of organotin-induced oxidative activity, indicating that the uptake
of Ca2+ at the mitochondrial level is necessary for the generation of reactive oxygen species
induced by organotins.
It is known that mitochondrial cytochrome c release from the inner membrane into the
cytosol is an early common event in the induction of apoptosis by multiple agents, and that
cytochrome c release is linked to caspase activation and subsequent DNA fragmentation
(Stridh et al., 1998). Like previously shown for TBTC (Stridh et al., 1998), we
demonstrate that also DBTC is able to induce the release of cytochrome c. The addition of
BAPTA or rotenone to the cells before the organotin compounds modulated cytochrome c
release, suggesting that the increase of intracellular Ca2+, ROS release and transport of
cytochrome c into the cytosol are early and functionally correlated events in the pathway
leading to DNA fragmentation induced by organotins. It is still difficult to temporally
separate the effect of organotin compounds on mitochondria and the release of
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cytochrome c (both events occurring within few minutes). Our results, based on the
modulatory effect of rotenone, led us to the proposal that ROS production precedes
cytochrome c release.
The subsequent step has been the evaluation of the possible involvement of caspases
during DNA fragmentation, knowing that a link between release of cytochrome c by TBTC
and activation of caspase 3 has been shown by Stridh et al. (1998) on Jurkat cells. Present
data indicate that inhibition of caspase 3 reduced the extent of DBTC-induced apoptosis,
confirming also for this compound the crucial role of the caspase family in the activation of
apoptotic cell death.
Thus, we conclude that both organotin compounds DBTC and TBTC initiate an increase
of [Ca2+]i, causing the generation of ROS and release of cytochrome c by mitochondria. As
a result caspases are activated, cleaving defined target proteins leading to an irreversible
apoptotic damage of the cell. The influx of Ca2+ may be caused by disruption of membrane
or cytoskeletal functioning. This has already been demonstrated for TBTC (Chow and
Orrenius, 1994) whereas DBTC has been found capable of cytoskeleton-mediated capping
of T cell receptor and CD8 molecules on thymocytes (Pieters et al., 1995).
Previously, it has been shown (Gennari et al., 2000, see also chapter 3) that both DBTC
and TBTC increased RNA synthesis in small high-density CD4+CD8+ thymocytes at
similar concentrations as used in the present study. Whether the early mitochondrial effects
and increased RNA synthesis are functionally linked, and whether the synthesized RNA
molecules play a role in the fragmentation of DNA, is subject of research.
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THYMUS-INDEPENDENT INHIBITION OF HAPTEN-INDUCED
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ABSTRACT
Previous studies have shown that thymus atrophy caused by the organotin compound di-
n-butyltin dichloride (DBTC) is the consequence of inhibition of immature thymocyte
proliferation. After prolonged exposure, the number of peripheral T cells as well as T
cell-mediated immune functions was found to be diminished, and this suppression of
peripheral immune response was hypothesized to be the result of reduced seeding of
mature thymocytes from the thymus to the peripheral immune organs. The apparent
thymus selectivity of organotin compounds, however, contradicted in vitro data, showing
that DBTC inhibited proliferation and induced apoptosis in both thymocytes and
splenocytes. Thus, we argued that DBTC may affect both thymocytes and T cells but
their vulnerability depends on the state of activation. To examine this, the effect of a
single oral dose of DBTC on a hapten (DNCB)-induced immunostimulation was
assessed. Rats were sensitized by painting 1% (w/v) DNCB on the ears, and the number
of DNP-specific IgG forming cells in the auricular lymph nodes were determined by
ELISPOT-assay. Results demonstrated that DBTC not only reduced the number of
thymocytes, but also the number of antibody forming cells. The fact that IgG production
is T cell-dependent, combined with the fast kinetics of reduction (3 days after DBTC
dosing), indicates that DBTC has a direct effect on peripheral T cell activation.
This study shows for the first time that organotin compounds are not thymus-selective,
but rather affect activation of T cells in general.
INTRODUCTION
The organotin compounds that have been most extensively studied are dialkyltin
compounds, such as di-n-butyltin dichloride (DBTC), used primarily as stabilizers for
polyvinyl chloride plastics, and trialkyltin compounds, such as tri-n-butyltin chloride
(TBTC), which are widely used as biocides (Fent, 1996).
In vivo, both of these organotins are known to induce thymus atrophy initiated by a
rapid reduction of the proliferation of thymocytes in rats (Penninks and Seinen, 1987;
Vos and Penninks, 1987; Snoeij et al., 1988). A single oral dose of DBTC induced a
marked decrease of the number of proliferating, immature CD4-CD8+TcRαβ-/low
CD4+CD8+TcRαβ-/low thymoblasts within 24 to 48 h. The large population of small, non
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dividing CD4+CD8+ thymocytes gradually decreased and was maximally reduced at day
4 to 5 after dosing, when the number of thymoblasts had returned to control level again
(Snoeij et al., 1988; Pieters et al., 1992). Within 7-9 days thymus weight and total
thymocyte count were back at the control level. No affection in the spleen weight was
observed (Snoeij et al., 1988).
From these data it was concluded that organotin compounds selectively inhibit
immature thymocyte proliferation. The selective effect on thymoblasts would generate
fewer small cortical thymocytes, a marked depletion of cortical thymocytes and profound
reduction in thymus weight (Penninks et al., 1985; Vos and Penninks, 1987; Snoeij et al.,
1988; Pieters et al., 1992). The decrease in the number of peripheral T cells, and the
suppression of T cell dependent immune functions after prolonged exposure (longer than
2 weeks) to organotin compounds, were considered to be the result of this primary effect
on the thymus.
Although in vivo findings appeared to reveal a selective effect of DBTC on immature
thymocyte proliferation, parallel in vitro studies demonstrated a general anti-proliferative
effect of the organotin compound. Notably, DBTC was found to inhibit the mitogen-
induced proliferation of splenic T and B lymphocytes as well as the spontaneous and
mitogen-induced proliferation of thymocytes (Seinen et al., 1979). Moreover, thymocytes
and peripheral spleen cells were equally sensitive to apoptosis-inducing concentrations of
DBTC (1-5 µM) (Gennari et al., 1997, see also chapter 2). This discrepancy between in
vivo findings, indicative of a thymus-selective effect, and the in vitro data, showing that
DBTC has a general anti-proliferative and apoptotic activity, has complicated the search
for the mechanisms involved in organotin-induced thymus-atrophy.
Here, we aimed to investigate whether organotin compounds have a direct effect on
peripheral lymphocyte activation. Therefore, the influence of a single oral dose of DBTC
on a epidermally elicited, hapten (2,4-dinitro-1-chlorobenzene, DNCB)-specific induced
immunostimulation was assessed.
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MATERIALS AND METHODS
Chemicals
DBTC, obtained from Johnson Matthay Alfa Products (Karlsruhe, Germany), was
dissolved in ethanol absolute (EtOH) (Merck, Darmstadt, Germany) and further diluted in
corn oil (250 ml per rat) to a final EtOH concentration of 5%. 2,4-dinitro-1-chloro-
benzene (DNCB) was obtained from Sigma (St. Louis, MO, USA).
For ELISPOT assays, Immobilon-P membranes (Immobilon PVDF Transfer, Millipore,
Etten-Leur, The Netherlands), dinitrophenyl human serum albumin (DNP-HSA) (Sigma),
bovine serum albumin (BSA, fraction V), and alkaline phosphatase-conjugated goat-anti-
rat IgG antibody (Kirkegaard & Perry Laboratories Inc., Gaithersburg, MD, USA) were
used.
Animals and treatment
Male Wistar-derived rats (U:Wu) were bred under specific pathogen-free conditions and
housed under standard conditions (room temperature ±20°C, relative humidity ±55%).
Rats were 4-5 weeks of age at the start of the experiments.
Fifty µl of a solution of DNCB (1% w/v in a 4:1 mixture of acetone and olive oil) was
applied on the dorsum of the ears on 3 consecutive days. Twenty four hours after the last
application, animals received a single oral dose of 0 or 20 mg DBTC/kg body weight in
corn oil. On day 7, rats were killed by decapitation and thymi, spleens and auricular
lymph nodes (ALN) were isolated. Single cell suspensions were then prepared from
thymi and ALN and used for further analyses.
Cell suspensions
ALN and thymi were minced to prepare single-cell suspensions and cells were collected
in ice-cold PBS (supplemented with 1% BSA in case of lymph nodes). After a washing
step, cells were counted by a Coulter counter ZM (Coulter Electronics, Luton, UK). In
case of thymocytes, numbers of small cells (diameter between 4.3 µM and 6.8 µM) and
large cells (diameter over 8.6 µM) were determined as described before (Snoeij et al.,
1988) by varying the threshold values on the Coulter counter.
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ELISPOT assay
The assay was performed as previously described (Schielen et al., 1995). Briefly, 5x105
cells/ml in PBS/1% BSA were incubated (37°C, 4 h) in wells containing DNP-HSA-
coated (overnight, 4°C) immobilon-P membranes as bottom. Thereafter, membranes were
washed and incubated with optimal dilutions of alkaline phosphatase-conjugated goat-
anti-rat IgG antibody at 4°C, overnight while shaking. After washing, spots were
developed by incubation with 5-bromo-4-chloro-3-indolylphosphate and nitro blue
tetrazolium as substrate. Specific antibody forming cells (AFC) per 106 cells were then
calculated from spot numbers counted with the aid of a stereomicroscope.
Statistics
Preceding statistical analysis, the number of AFC/106 cells was transformed to log10
values to homogenize variance. Statistical analysis was determined by Student’s t test.
RESULTS AND DISCUSSION
In the present study, we tested whether the anti-proliferative effect of the organotin
compound DBTC is solely thymus-specific or whether DBTC is capable of directly
inhibiting proliferation of peripheral lymphocytes as well. For this purpose, rats were
immunosensitized by painting the allergen DNCB on the ears on 3 consecutive days
(Kimber et al., 1989). One day after the last application of DNCB, when proliferation in
the draining lymph node is known to be high and restricted to the T cell harbouring
paracortical region of the lymph node (Kimber et al., 1989), an anti-proliferative dose of
DBTC (20 mg/kg body weight) was given by gavage. This dose caused a significant
decrease of the relative weight of the thymus on day 7 (Fig. 1A). The number of both
small and large thymocytes (Fig. 2) was reduced as well, to around 50% and 45%
respectively. No loss in body weight gain (not shown) or changes in spleen weight (Fig.
1B) were observed. These findings are in agreement with previous data (Snoeij et al.,
1988; Pieters et al., 1992) and suggestive of a thymus selective effect of DBTC.
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Fig. 1. Relative thymus (A) and spleen (B) weight isolated from rats first sensitized with DNCB (1%w/v)
and then orally treated with 20 mg DBTC/kg body weight. The average ± SD of four animals per treatment
is shown. **p < 0.01.
But, most interestingly, assessment of the hapten-induced immunostimulation showed
that the total number of ALN-cells, as well as the number of DNP-HSA-specific IgG
forming cells per whole lymph node, were also significantly (p<0.03 and p<0.05
respectively) decreased in DBTC-treated rats (Table 1).
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Fig. 2. Number of small (A) and large (B) thymocytes after treatment with 20 mg DBTC/kg body weight.
The average ± SD of four animals per treatment is shown. *p < 0.05.
After the time period between dosing with DBTC and reading out the response to
DNCB (3 days) thymus atrophy is not yet maximal. This period is also too short to
explain a diminishment of peripheral T cells from a result of decreased seeding of recent
thymic emigrants into the periphery. Thus, it can be concluded that DBTC directly affects
the proliferation of lymphocytes in peripheral lymphoid organs.
The number of antibody forming cells per 106 was also reduced but not significant
(p<0.06), indicating that the relative number of B cells was less affected than the total
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number of lymph node cells and the absolute number of B cells. It is tempting to suggest,
from these data, that DBTC primarily affects proliferation of T cells, and that the
reduction of antibody formation is secondary to an inhibitory effect on T cells. In fact in
the presently used method, proliferation on the day after the last application of DNCB has
been shown to be restricted to T cells. However, also proliferation of total spleen cells
induced by LPS (Seinen et al., 1979) and of tonsilar B cells with Staphylococcus aureus
(De Santiago et al., 1999), has been shown to be inhibited by DBTC in vitro. This
suggests that even B cells, providing that they are activated, may be sensitive to DBTC.
Table 1. Number of draining auricular lymph nodes and AFC-IgG after DBTC
(20 mg/kg body wt.) treatment.
Treatment Cells count
(1x106)
AFC-IgG/
lymph node
AFC-IgG
(1x106)
Control 29.4 ±  4.3 3.3 ±  0.4 1.8 ±  0.3
DBTC 15.8 ±  2.0* 2.6 ±  0.2* 1.4 ±  0.2
*p < 0.05, compared to controls.
The reason why until now the general anti-proliferative capacities of DBTC have been
unnoticed, is due to the fact that the compound has never been tested directly on an
activated immune system. All indications of an immunosuppressive state induced by
thymotoxic organotins that were previously noticed, were obtained in rats dosed for 2
weeks or longer (Seinen et al., 1977; Vos et al., 1984). The need for activation also
applies to thymocytes, as it has been shown that the inhibitory effect of DBTC was
dependent on the proliferation rate of thymocytes, and that PHA-stimulated thymocyte
subsets are more sensitive to the anti-proliferative effect of DBTC (Pieters et al., 1994).
The present findings that DBTC, and possibly also other thymotoxic organotin
compounds, have a direct thymus-independent effect on T cell-dependent immune
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functions, may have important implications for studying the mechanisms of organotin-
induced immunosuppression.
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The aim of this thesis was to investigate whether apoptosis is responsible for the thymus
atrophy induced by organotin compounds at anti-proliferative doses, whether DBTC is
able to induce apoptosis in vitro, and to define the mechanisms involved in DBTC- and
TBTC-DNA fragmentation.
Moreover, it was tested whether organotin compounds have a selective effect on the
thymus or rather have a general anti-proliferative effect.
The organotin compounds di-n-butyltin dichloride (DBTC) and tri-n-butyltin chloride
(TBTC) are known to cause thymus atrophy in rats (Seinen and Willems, 1976; Seinen et
al., 1977; Vos et al., 1984). Initially, these chemicals inhibit the proliferation of large
immature thymoblasts, leading to a reduction in the population of CD4+CD8+ thymocytes,
which are the descendants of the initially affected thymoblasts (Snoeij et al., 1988; Pieters
et al., 1992).
The aim of the second chapter of this thesis was to examine whether apoptotic cell death
is involved in this thymus atrophy. Results showed that neither of the tested DBTC or
TBTC induced apoptosis in thymi of animals exposed to a single oral dose (15 mg/kg),
which is known to inhibit thymocyte proliferation. In contrast, parallel in vitro studies
revealed that a short exposure to relatively high concentrations (3-5 µM) of organotins
induced DNA fragmentation in rat thymocytes and spleen cells. Higher concentrations or
prolonged exposure of organotins induced necrosis instead of apoptosis, and this could
explain why until now the potency of DBTC to stimulate apoptosis in vitro was resulted
unnoticed (only 1-6 h of incubation has been tested) (Aw et al., 1990; Raffray and Cohen,
1993). Thus, apoptosis appears to be not responsible for organotin-induced thymus atrophy
at a dose that inhibits immature thymocyte proliferation, although it might be involved at
high doses of the compounds (Raffray and Cohen, 1993; see also appendix).
Because of the cytotoxic effects of DBTC or TBTC (see chapter 1), we aimed to further
investigate the mechanisms underlying in vitro organotin-induced DNA fragmentation.
At lower concentrations than required to induce apoptosis, both compounds were capable
of inhibiting synthesis of protein and DNA, and triggering de novo synthesis of heat shock
proteins (HSPs). The possible relation between organotin-induced apoptosis and
macromolecular synthesis has been investigated in chapter 3, with a particular interest on
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DBTC that is considered the most potent thymotoxic compound (Snoeij et al., 1988). We
have demonstrated that DBTC increased the synthesis of RNA in small high-density
thymocytes (CD4+CD8+), like already shown for TBTC (Snoeij et al., 1986). Results
indicated that organotin-induced apoptosis affected the same subset of small thymocytes
CD4+CD8+ and furthermore, that the process was RNA- and protein-synthesis dependent.
Notably, the combination of the RNA and protein synthesis inhibitors (actinomycin D and
cycloheximide, respectively) with DBTC or TBTC decreased the amount of DNA
fragmentation induced by organotin compounds alone.
The need of de novo protein synthesis during apoptosis was somewhat surprising,
considering that both organotins are potent protein inhibitors.
Organotin compounds induced synthesis of the heat shock protein HSC73, at
concentrations that inhibited protein synthesis to around 20%. Heat shock (HS) by itself,
however, was not able to increase apoptosis in rat thymocytes, contrasting previous results
which indicated that HS could induce DNA fragmentation in mouse thymocytes, probably
because of differences in strain-specificity (Migliorati et al., 1992). Because cyclohexi-
mide, which by itself did not increase apoptosis, also induced heat shock proteins (HSPs),
we concluded that the production of HSC73 by organotins was not due to a direct effect of
the compounds, but more to a consequence of the inhibition of protein synthesis.
So, as we found that DBTC and TBTC increased synthesis of RNA, we aimed at
identyfing the newly synthesized RNA molecules. In chapter 4, we therefore used the
cDNA macro-array technique, which allows the analysis of multiple genes apoptosis-
related simultaneously, to assess whether and if so which genes are translated after short
exposure of rat thymocytes to DBTC. Two genes, glutathione S-transferase (GST) and
nur77, were found to be activated under influence of apoptotic doses of DBTC, and both of
them are known to be involved in the apoptotic process by various other chemicals
(Flomerfelt et al., 1993; Winoto, 1994). GST, an antioxidant defence enzyme involved in
cellular detoxification (Mannervik and Danielson, 1988), was proposed to be regulated by
ROS (Rushmore et al., 1991). It seems that an increase of GST-level in apoptotic cells
could be related to an enhanced production of ROS, indicating a situation of oxidative
stress rather than a required step in the apoptotic pathway (already shown in case of
steroid-induced apoptosis, by Flomerfelt et al., 1993).
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Nur77 is a member of the steroid/thyroid hormone receptor superfamily, previously
shown to be expressed during TCR-mediated apoptosis (Liu et al., 1994; Winoto, 1994),
regulated by calcium signals (Woronicz et al., 1995). We found that blocking the
transcription of nur77 effectively decreased the percentage of apoptotic nuclei by DBTC,
confirming that nur77 is responsible for the activation of the apoptotic process induced by
organotins.
Besides effects on macromolecular synthesis, DBTC and TBTC are known to disrupt
energy metabolism (Cain et al., 1977; Snoeij et al., 1986). TBTC has been observed also to
rapidly increase the level of intracellular calcium, which is linked to a subsequent
endonuclease activation and DNA fragmentation (McConkey et al., 1989; Chow et al.,
1992). At mitochondria level, TBTC caused formation of reactive oxygen species (ROS),
release of proapoptotic factors, such as cytochrome c, and activation of caspases (Corsini et
al., 1996; Stridh et al., 1998). In chapter 5 we demonstrated the similarity between the
organotin compounds DBTC and TBTC in the pathway followed to initiate apoptosis. An
initial increase of calcium, followed by ROS production and release of cytochrome c from
the mitochondrial membrane into the cytosol was also evident in case of DBTC. Also
caspase 3 was found to be activated by DBTC, resulting in DNA fragmentation and cell
death. ROS generation, cytochrome c release, and DNA fragmentation were reduced when
organotin compounds were used in combination with the calcium chelator BAPTA, or with
the electron transport chain-inhibitor rotenone. This indicates the important role of
intracellular calcium and mitochondria in organotin-induced apoptosis.
It can be hypothesized that the cellular membrane is the first target of organotins. At
relatively low concentrations/doses this leads to a proliferative arrest due to disturbance in
metabolism, ATP reduction, protein and DNA synthesis inhibition. At higher concen-
trations/doses, a series of events, partly correlated, initiate the apoptotic process (fig. 1).
The increase of calcium is one of the earliest steps, which might regulate the activation of
the DNA binding transcription factor nur77 as well, and it is followed by ROS and
consequent GST production.
An increase of the permeability of the inner mitochondrial membrane (permeability
transition, PT) is linked to the dissipation of the inner transmembrane potential (∆Ψ) and to
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the release of the pro-apoptotic factor cytochrome c to the cytosol. Cytochrome c activates
caspase 3, which cleaves specific substrates contributing to the process of apoptotic cell
death.
Fig. 1. Schematic representation of the events involved in proliferative inhibition and apoptosis induced by
organotin compounds. ∆ψ: mitochondrial membrane potential. Dots indicate the cytochrome c molecule.
From low to high concentrations means: from 0.1 µM to 3-5 µM. From low to high doses means: from 15
mg/kg to 60 mg/kg.
It is not possible to say which one of these above mentioned events is the crucial one in
organotin-induced apoptosis. Each of them is involved in the initiation of the apoptotic
process, and the inhibition of one single step can reduce the extent of DNA fragmentation
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but not completely prevent the process. It means that the events, although linked to each
other, can independently be activated and bring the cell to an irreversible damage.
In conclusion, DBTC- or TBTC-induced apoptosis is a mechanism of cell death relevant
both in vitro and in vivo at relatively high concentrations/doses of compounds, while lower
concentrations/doses of organotins result in anti-proliferative effects without the
involvement of the apoptotic process.
Previously, it has been shown in vitro that DBTC is able to inhibit not only the
proliferation of thymocytes, but also of T and B splenic cells (Seinen et al., 1979).
Moreover, in the second chapter of this thesis (Gennari et al., 1997), it is shown that
organotin compounds induce apoptosis in rat splenocytes at the same concentrations as in
case of thymocytes. In the last chapter, we tested whether DBTC, in vivo, had a direct
effect on peripheral T cell responsiveness. Interestingly, we found that DBTC could
directly and rapidly (in 3 days) inhibit a hapten (DNCB)-specific immune response,
reducing the number of peripheral cells and antibody forming cells (IgG) isolated from
auricular lymph nodes of sensitized animals (chapter 6).
This finding has important implications for studying mechanisms of action of organotins,
as it means that focus no longer has to be on inhibition of immature thymocyte
proliferation but on lymphocyte proliferation in general.
In conclusion, the results described in this thesis confirm that DBTC and TBTC induce
apoptosis in vitro, at relatively high concentrations. For both compounds, the apoptotic
mechanism is dependent on RNA and protein synthesis (two new molecules up-regulated
by organotins have been identified) and is initiated at mitochondria level, with the
involvement of calcium, ROS, cytochrome c and caspases.
In vivo data indicate that apoptosis is not evident at a dose of organotins known to
inhibit thymocyte proliferation.
Finally, DBTC has been found to be not thymus-selective, but to have a direct inhibitory
effect on the peripheral immune responsiveness.
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APPENDIX
Re: Organotin-induced apoptosis as observed in vitro is not relevant for induction of
thymus atrophy at antiproliferative doses (article n. TO978265)
To the editor:
These authors refer to findings previously published by us (Raffray and Cohen, 1993)
on thymic atrophy caused in vivo by tributyltin (TBT), and we would like to offer the
following comments:
1. The two studies should be considered in terms of molar dose of TBT. Their selection
of a single dose level of 20 mg kg-1 tri-n-butyltin chloride (TBTC) po represents 55 µmol
kg-1 TBT. Our study was conducted with bis(tri-n-butyltin)oxide (TBTO), not with TBTC
as they stated, at po doses of 30 or 60 mg kg-1, which represent 98 or 196 µmol kg-1
TBT, respectively. This difference alone significantly complicates comparison of effect
between the two studies.
2. Assessment of thymic cell counts from both studies indicates clear differences in the
respective kinetics of thymocyte depletion:
Percentage of control at the
indicated time point
Treatment 18 h 24 h 36 h 48 h
TBTC
TBTO
20 mg kg-1
60 mg kg-1
(Gennari et al., 1997)
(Raffray and Cohen, 1993)
—
75
101
—
—
54
58
36
Thus the immunohistochemical and flow cytometric assay evaluations of apoptosis
incidence shown in their paper were conducted at a time point (24 h) at which no
decrease in total thymocyte count had yet occurred. They comment upon a similar
absence of effect after 48 h, but no results are presented.
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3. Their paper emphasizes the absence of free apoptotic cells in thymic tissue sections
from animals dosed with TBT. This was also the case in our work with TBT, which was
clearly stated by us, and is not in dispute. However, they did not address our comparative
cytopathology findings which demonstrated treatment-related increases in phagocytes
with included apoptotic thymocytes. Increased macrophage clearance activity in the
thymus following triorganotin administration to rodents (at equivalent doses) has been
independently noted by two other laboratories (De Waal et al., 1993; Kempson et al.,
1993).
4. Although they contend that, in vivo, di-n-butyltin (DBT) from metabolic dealkylation
of TBT rather than TBT itself is the toxicologically active agent, it is highly unlikely that
all TBT is dealkylated prior to significant exposure of thymus to potentially cytotoxic
concentrations of TBT (see toxicokinetics data in Humpel et al., 1986; and also Snoeij,
1987). In this context, even their own in vitro work with a brief (10 min) exposure of
thymocytes to TBT, followed by washout, shows significant stimulation of apoptosis is
possible at concentrations relevant to blood concentrations in vivo.
5. A deficiency in our study was the absence of stress-glucocorticoid measurements
(this parameter was also not assessed in their study). However, certain pieces of indirect
evidence we referred to, and also comparative literature data, indicate that stress-
glucocorticoid-induced thymocyte apoptosis is unlikely to have been a significant feature.
6. In conclusion, it is undisputed that antiproliferative mechanisms are important in
organotin thymotoxicity. However, TBT and also DBT are now known to be very
cytotoxic. The title of our 1993 paper proposed consideration of apoptosis as “ a
mechanism” in triorganotin thymotoxicity, not as “ the mechanism,” and we did not rule
out concurrent antiproliferative effects. Based on the available data set in the literature, it
is our opinion that apoptotic deletion of thymocyte can contribute to triorganotin
thymotoxicity in vivo, and that such an effect will be increasingly relevant at moderate to
high organotin doses. In such models the relative contribution of antiproliferative and
antidevelopmental effects on thymocytes versus cytotoxicity remains to be established in
quantitative terms. There is often a natural tendency to oversimplify the behaviour of
experimental systems in the search for a single unifying mechanism, but this may be a
misleading approach in the case of triorganotin thymotoxicity. A plausible working
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hypothesis is that a composite mechanism is involved in cortical thymocyte depletion,
involving complex antiproliferative or antidevelopmental effects and also cytotoxicity
resulting in the activation of apoptosis.
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GERALD M. COHEN
Reply
To the editor:
The aim of our study was to examine whether an increase of apoptosis occurred at doses
of organotin (tributyltinchloride, TBTC, or dibutyltinchloride, DBTC) that were
previously found to be selectively inhibit immature thymocyte proliferation
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(demonstrated previously by decrease of DNA synthesis and number of thymoblasts).
Because this inhibition of proliferation was maximal 24-48 h after dosing and thereafter
recovered to reach control level again on days 4-5 after dosing, we focused on these
mechanistically important early time points.
The main conclusion that can be drawn from our results is that at relatively low,
antiproliferative doses of DBTC or TBTC there is no increase in apoptotic thymocytes on
24 or 48 h after dosing. By hypothesizing that low doses of these compounds have a mere
antiproliferative effect (on immature CD4-CD8+CD3- thymocytes) all ensuing
phenotypical and kinetic intrathymic changes can be explained. We fully agree with
Raffray and Cohen that at higher doses of either of these organotin compounds, apoptosis
and eventually also necrotic cell death may become of increasing importance and
eventually the major mechanism involved. This dose dependency of the in vivo effects is
reflected in in vitro experiments showing that inhibition of DNA synthesis is affected by
concentrations of TBTC or DBTC that are 10 or 30 times as low as those that induce
DNA fragmentation.
But although apoptosis is not unlikely to be involved at high doses, it is unclear from
data of Raffray and Cohen (1993) whether they found an increase of apoptosis on a whole
organ base. They show an increase in DNA fragmentation from ±10 µg DNA
fragments/108 thymocytes in controls to 45 µg of DNA fragments/108 thymocytes in the
60 mg/kg group, but thymi of this latter group harbor only of 30% of the control
thymocyte number: thus on a whole organ base there seems only a minor increase from
approximately 10 to 15 µg of DNA fragments/thymus. Although the blood level of
glucocorticosteroids is not elevated, this slight increase in DNA fragmentation might be
explained by moderate stress, that may also underlie the slight loss in body weight at
higher doses (30-60 mg TBTO/kg, Raffray and Cohen, 1993; 35 mg TBTC/kg, Snoeij et
al., 1985). If apoptosis would occur at the high doses, then it is also not surprising that
macrophages appear in the thymus to clear cell remnants (Raffray and Cohen, 1993);
however, at antiproliferative doses of DBTC we did not observe an increase in the
absolute number of ED2+ - or ED1+ -cortical macrophages (Pieters et al., 1988).
It might seem logical to compare TBTC and TBTO (containing two TBT groups
attached by oxygen) based on the molals of the bioactive TBT+ they release. If true, it
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would suffice to use half the dose (in mg/kg body wt) of TBTO to obtain the same effect
as in the case of TBTC, implying that Raffray and Cohen used a much higher dose then
we did (compare our 55 µmol/kg with their 195 µmol/kg). But both LD50 doses (122 mg
TBTC/kg and 127 mg/kg TBTO, Schweinfurth, 1985) as well as thymotoxic doses
(reduction of thymus weight: 56 and 43% at 25 mg/kg TBTO and TBTC respectively,
Bressa et al., 1991) are similar on a mg/kg base and also ED50 concentrations that inhibit
DNA synthesis in vitro are comparable (compare Snoeij et al., 1985, with Vos et al.,
1984). Apparently, hydrolysis of TBTO to 2x TBTOH and subsequent reaction to TBT+
salt (Bock et al., 1962) is less efficient than dechlorination of TBTC to TBT+. This
would mean that the TBTO and TBTC are more comparable at the mg/kg than at the
molar base.
Thymic effects of TBTC and DBTC upon single iv treatment
Compound Dose n Body wt (g) Rel. thymus wt
(mg/kg) (mg/g)
0 5 77.3±4.6 3.73±0.73
0 15 76.5±3.8 3.67±0.61
DBTC 0.5 5 78.7±5.6 3.36±0.61
1.0 5 76.8±2.0 2.74±0.47*
2.5 5 78.9±3.7 2.48±0.41**
TBTC 0.5 5 79.1±3.8 3.47±0.38
1 5 76.5±4.6 3.74±0.42
2.5 5 78.1±2.1 3.70±0.46
2.5 15 78.7±3.8 3.40±0.51
Note. Mean ± SD, *p<0.01, **p<0.001.
Finally, we fully agree with Raffray and Cohen that debutylation of TBT+ to DBT+ is
incomplete, and much TBT+ appears in the circulation after oral exposure to TBTC
(Snoeij, 1987). Most data that support the idea that TBT must be converted to DBT to
become biologically active are given in Snoeij et al., (1988). Further support for the idea
that TBTC itself is not directly thymotoxic and must be metabolized (to DBT+) via the
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oral route comes from an additional series of experiments, that is not published in
international literature (Snoeij, 1987) and given in the table. It shows that intraveneous
treatment with DBTC but not with TBTC causes thymus atrophy. Thus, despite the fact
that the blood concentration of TBTC is high, no thymic effects are induced, whereas
DBTC is very potent in inducing thymus atrophy via the intraveneous route.
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SAMENVATTING IN HET NEDERLANDS
Organotinverbindingen vormen een groep van stoffen die een breed scala aan
toepassingen kent en in volume de meest geproduceerde organometaalverbindingen zijn.
De bekendste van deze verbindingen zijn de organotinverbindingen waarbij aan een tin-
atoom drie aryl- of alkyl-groepen gesubstitueerd zijn. Sommige van deze
trialkyltinverbindingen worden gebruikt als schimmeldodend middel (fungicide) in de
aardappelteelt, anderen zijn vooral bekend als bestanddeel van aangroeiwerende verven
op scheepshuiden. Een probleem bij deze toepassing is dat de stoffen uit de verven lekken
en in het water terecht komen. Vanwege de hormoonverstorende werking van
trialkyltinverbindingen bij zoutwaterslakken worden deze stoffen in verband gebracht
met de achteruitgang in de populatie purperslakken en wulken in onze kustwateren.
Een minder bekende klasse van organotinverbindingen wordt gevormd door stoffen
waarbij slechts twee alkylgroepen aan het tin-atoom vastzitten. Deze
dialkyltinverbindingen worden gebruikt als katalysatoren in de polyurethaansynthese
(PUR-schuim) en als stabilizatoren in PVC plastics. De organotinverbindingen die in dit
proefschrift gebruikt zijn, zijn tributyltinchloride (TBTC) en dibutyltin dichloride
(DBTC).
Door de brede toepassingsmogelijkheden is het gebruik en produktie van deze stoffen
sinds hun ontwikkeling halverwege de vorige eeuw enorm toegenomen. Deze toename
heeft er ook toe geleid dat de giftigheid van deze stoffen grondig onderzocht is. Maar pas
rond 1976 werd uit proefdierexperimenten bekend dat met name het afweersysteem
gevoelig is voor dibutyltinverbindingen, hetgeen later ook het geval bleek voor
tributyltinverbindingen. Het meest opvallende effect van de verbindingen is een
verandering in de thymus, beter bekend als de zwezerik. De verbindingen zorgen
namelijk voor een verschrompeling van de thymus, een effect dat ook wel aangeduid
wordt als thymusatrofie.
De thymus vervult in het afweer of immuunsysteem een belangrijke, centrale functie. In
dit orgaan vindt namelijk de ontwikkeling plaats van T (Thymus-afhankelijke) cellen.
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Deze cellen vervullen een dirigerende rol in de afweerreactie tegen bijvoorbeeld
bacteriën, virussen en tumoren. Tijdens de ontwikkeling in de thymus leren onrijpe pre-T
cellen, die afkomstig zijn uit het beenmerg, waartegen ze wel en waartegen ze niet mogen
reageren. Tijdens deze, bijzonder ingewikkelde, T-celontwikkeling spelen tal van
processen een rol. In eerste instantie vindt er een sterke vermeerdering van pre-T cellen
plaats. Tijdens deze vermeerdering verschijnen er op de buitenkant van de cellen zeer
specifieke receptoren, T cell receptoren, die fragmenten van eiwitten kunnen herkennen.
Vervolgens wordt, nog in de thymus, nagegaan of de T cellen daadwerkelijk iets kunnen
herkennen. Dit is nodig om te kunnen reageren op een ongewenste indringer, zoals een
bacterie. Maar ze mogen ook weer niet te heftig reageren op stukjes eiwit die van nature
in ons lichaam aanwezig zijn. Dit laatste zou namelijk kunnen zorgen voor een
afweerreactie tegen de eigen organen of weefsels. Het is na vele jaren van onderzoek
gebleken dat T cellen die helemaal niet reageren en ook T cellen die te sterk reageren in
de thymus afsterven. Het stervensproces is een nauwkeurig gecontroleerd proces dat
apoptose genoemd wordt. Bij apoptose wordt de cel zodanig opgeruimd dat dit geen
overmatig celdebris, met als mogelijk gevolg ontstekingen, oplevert. Kenmerkend voor
dit proces is dat het DNA netjes afgebroken wordt en dat het afhankelijk is van de
metabole aktiviteit van de cel.
Sinds de ontdekking dat tri- en dibutyltinverbindingen een effect op de thymus hebben is
veel onderzoek gericht op de gevolgen van het effect voor de afweer. Bovendien is er veel
energie gestopt in het ophelderen van het werkingsmechanisme van deze stoffen, met
andere woorden in het karakteriseren van de processen waarvan de verstoring cruciaal is
voor het gevonden effect.
Uit het onderzoek bleek al snel dat het effect op de thymus uiteindelijk leidt tot een
afname van T cellen in de rest van het lichaam, vooral in de milt en de lymfknopen. Deze
afname heeft op haar beurt gevolgen voor het functioneren van de afweerreactie, met name
de T cel-afhankelijke afweerreacties. Ook is al vroegtijdig gebleken dat met name TBTC
en DBTC behoorlijk giftig zijn voor T cellen als ze in een kweekbuis direct in contact
gebracht worden met de stoffen. Bij lage concentraties wordt met name de celdeling van T
cellen geremd. Hoe dit precies in zijn werk gaat is nog steeds onduidelijk maar
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vermoedelijk grijpen deze stoffen tegelijkertijd aan op meerdere processen in de cel,
waardoor een verstoring van de energiehuishouding en uiteindelijk een remming van
energievragende processen optreedt. Ook in ratten die aan lage doseringen werden
blootgesteld is een afname van de celdeling in de thymus gevonden. Bij een eenmalige
blootstelling blijft dit effect beperkt tot de thymus, hetgeen heeft geleid tot de conclusie
dat deze stoffen thymus-selectief werken.
Recenter is gebleken, met name in geval van de trialkyltinverbindingen, dat hogere
concentraties celdood, door middel van apoptose, tot gevolg hebben. In een vervolg op
deze reageerbuis-experimenten werd aangetoond dat hoge doseringen
trialkyltinverbindingen ook apoptose in de thymus van ratten kunnen veroorzaken. Deze
bevinding was deels in tegenspraak met de eerdere ideëen dat organotinverbindingen met
name de celdeling verstoorde en bovendien met het vermoeden dat trialkyltinverbindingen
omgezet worden in dialkyltinverbindingen en dat deze laatste verbindingen het
uiteindelijke effect hebben.
Het eerste doel van het onderzoek beschreven in dit proefschrift was dan ook om na te
gaan of DBTC, net als TBTC, apoptose kan veroorzaken in de thymus van de rat. En
indien dat zo zou zijn, na te gaan welke biochemische processen bij dit proces van
apoptose een rol spelen.
Een ander belangrijk doel van dit onderzoek was om na te gaan of deze stoffen, met
name DBTC, alleen de celdeling in de thymus verstoort. Dit was belangrijk omdat
jarenlang onderzoek, beschreven in een viertal proefschriften, nog steeds niet had
uitgewezen waarom nou juist celdeling in de thymus gevoelig is voor DBTC. Hierbij dient
nog opgemerkt te worden dat in de reageerbuis zowel de deling van T cellen uit de thymus
als van T cellen uit de milt geremd wordt door DBTC.
Het onderzoek beschreven in hoofdstuk 2 van dit proefschrift toont aan dat apoptose niet
optreedt bij doseringen (15-20 mg/kg lichaamsgewicht) die al wel de celdeling remmen in
de thymus. Bovendien wordt in dat hoofdstuk aangetoond dat DBTC in de reageerbuis
ook, net als TBTC, in staat is apoptose te veroorzaken, en niet alleen in T cellen uit de
thymus maar ook in T cellen uit de milt (!)
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In hoofdstuk 3 wordt het proces van apoptose als gevolg van DBTC nader bestudeerd.
Hieruit blijkt dat met name een speciaal type van T cellen uit de thymus, namelijk de
onrijpe en apoptose gevoelige dubbelpositieve cellen (deze cellen hebben zowel een CD4
als een CD8 receptor), gevoelig zijn voor celdoding door DBTC. Tijdens dit proces vindt
er in deze cellen een nieuwvorming plaats van RNA-moleculen en bepaalde eiwitten die
heat-shock eiwitten genoemd worden. Remming van de RNA synthese of de eiwitsynthese
verhindert de apoptose als gevolg van DBTC hetgeen aangeeft dat de nieuwvorming
essentieel is voor het optreden van apoptose. Onduidelijk blijft in dit hoofdstuk voor welk
eiwit deze RNA-moleculen coderen. Wel is duidelijk dat dit waarschijnlijk niet de heat-
shock eiwitten.
De verdere karakterisatie van de nieuwgevormde RNA-moleculen is gedaan in hoofdstuk
4 met behulp van de cDNA macro-array techniek. Twee genen, één coderend voor
glutathione S-transferase (GST) en één voor nur77, bleken toegenomen in T cellen uit de
thymus na kortdurende blootstelling aan DBTC. GST is betrokken bij de ontgiftiging of
detoxificatie-mechanismen van cellen en wordt gereguleerd door reactieve
zuurstofmoleculen die in een vergiftigde cel kunnen ontstaan. Nur77 is een lid van een
zogenaamde superfamilie van hormoonreceptoren, de steroid/thyroid hormone receptor
superfamilie, en is betrokken bij apoptose in thymale T cellen. Aktivatie van nur 77 wordt
geregeld door calcium signalen. Bijzonder interessant is dat door de transcriptie van nur77
te blokkeren door middel van een stukje complementair DNA, de apoptose als gevolg van
DBTC voor een aanzienlijk deel geremd wordt. Dit toont aan dat nur77 inderdaad een rol
speelt in het apoptose-proces dat door DBTC geaktiveerd wordt.
Het mogelijke verband tussen verstoorde cellulaire processen en apoptose wordt
bestudeerd in hoofdstuk 5. Hierin wordt beschreven dat TBTC en DBTC via een
vergelijkbare verstoring van processen apoptose veroorzaken. Beide stoffen blijken in
staat om de concentratie van calcium te verhogen, de produktie van reactieve
zuurstofmoleculen te induceren, te zorgen voor het vrijkomen van cytochroom c uit
mitochondria in het cytosol en caspase 3 te aktiveren. Al deze processen kunnen in meer
of mindere mate bijdragen aan het proces van apoptose, hetgeen blijkt uit studies waar
calcium specifiek wordt weggevangen of waarbij de vorming van reactieve zuurstof
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radicalen geremd wordt. Ook onderdrukking van caspase 3 werking remt de apoptose als
gevolg van de DBTC.
In hoofdstuk 6 wordt in een proefdiermodel nagegaan of DBTC ook een effect heeft op T
cel-deling buiten de thymus. In dit model wordt een immuunrespons opgewekt, door een
immunostimulerende allergene verbinding (DNCB) op drie achtereenvolgende dagen op
het oor van een rat aan te brengen. De immuunreactie is na een week afgelezen aan de
hand van zwelling (celaantal) van de lymfknoop die dicht bij het oor gelegen is.
Bovendien is de immunologische aktiviteit (antilichaamreactie tegen de verbinding
DNCB) in de knoop bepaald. DBTC werd aan dezelfde rat gegeven op het moment dat de
celdeling in de knoop maximaal was (4 dagen na de eerste keer opbrengen). Uit de
resultaten blijkt dat DBTC wel degelijk in staat is ook de celdeling te remmen van T cellen
in de lymfknoop, dus buiten de thymus. Dit is nooit eerder opgemerkt, waarschijnlijk
omdat altijd gekeken is in ratten die immunologisch in rust waren of in dieren die al
langere tijd blootgesteld waren aan organotinverbindingen zodat elk effect buiten de
thymus verdoezeld werd door de gevolgen van de thymusatrofie, namelijk een
verminderde uitstroom van uitgerijpte T cellen. De nieuwe bevinding kan een duidelijke
invloed hebben op eventueel verder onderzoek naar de werkingsmechanismen van
organotinverbindingen omdat de te onderzoeken processen betrokken bij celdeling of
proliferatie nu niet meer thymus-specifiek hoeven te zijn.
Wat het werkingsmechanisme van organotinverbindingen betreft is er met dit
proefschrift een duidelijke stap voorwaarts gezet: lage concentraties of doseringen remmen
de celdeling, hoge concentraties of doseringen induceren apoptose. In beide gevallen is
een afname van T cellen in de thymus of daarbuiten het gevolg. Onduidelijk en waard te
onderzoeken blijft of vergelijkbare celbiologische en biochemische processen betrokken
zijn bij zowel remming van celdeling als inductie van apoptose door
organotinverbindingen.
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RIASSUNTO IN ITALIANO
Gli organostannici sono composti chimici utilizzati in svariati settori, ad esempio in
campo industriale come catalizzatori e stabilizzatori o in agricoltura come pesticidi.
L’interesse nei confronti dei dialchil- e trialchil-derivati (tra cui il DBTC ed il TBTC) è
dovuto alla loro azione immunotossica nei roditori. Poichè il primo bersaglio di questi
composti è il timo, lo scopo di questa tesi è stato quello di esaminare i meccanismi
cellulari e molecolari responsabili dell’atrofia timica, con un particolare interesse al
possibile coinvolgimento dell’apoptosi nella morte cellulare.
Mentre in vitro gli organostannici hanno un effetto antiproliferativo su diversi sistemi
cellulari, in vivo mostrano una selettività verso il timo, dove provocano una riduzione del
peso e della cellularità. Nel secondo capitolo della tesi, in cui abbiamo condotto studi per
esaminare se l’apoptosi potesse essere coinvolta in questa atrofia timica, non sono state
osservate cellule apoptotiche nel timo di animali esposti a dosi di DBTC o TBTC (15-20
mg/kg) in grado di inibire la proliferazione di timociti. Gli studi in vitro hanno evidenzia-
to in timociti e splenociti di ratto incubati per breve tempo (10 min) a concentrazioni
relativamente alte (3-5 µM) di stanno-derivati, la frammentazione del DNA e quindi la
capacità di questi composti di indurre apoptosi.
Poichè il DBTC ed il TBTC rappresentano dei potenziali modelli di studio per
esaminare i meccanismi d’azione dei composti chimici in grado di provocare apoptosi,
abbiamo deciso di approfondire la nostra ricerca in vitro sui meccanismi molecolari alla
base dell’apoptosi indotta da organostannici nei timociti di ratto.
E’ noto che a concentrazioni minori di quelle richieste per indurre l’apoptosi, gli stanno-
derivati inibiscano la sintesi proteica e di DNA ed aumentino la sintesi di RNA e di heat
shock proteins (HSPs). Nel terzo capitolo, abbiamo dimostrato che il DBTC (in maniera
simile al TBTC) stimola la sintesi di RNA nei timociti di classe CD4+CD8+, che
comprende lo stesso gruppo di cellule sensibili all’apoptosi. Inoltre abbiamo dimostrato
che il processo apoptotico è dipendente dalla produzione di RNA e di proteine, in quanto
l’aggiunta degli inibitori di sintesi riduce l’estensione della frammentazione del DNA
indotta sia dal DBTC che dal TBTC. E’ interessante notare che nonostante gli stanno-
derivati inibiscano la sintesi proteica, siano in grado di indurre la proteina heat-shock
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HSC73. Questa apparente discordanza, può essere spiegata considerando che le HSPs
sono prodotte in seguito ad uno stress cellulare, come meccanismo di difesa, quindi la
produzione di HSC73 non è dovuta ad un effetto diretto degli stanno-derivati, ma
piuttosto è una conseguenza dell’inibizione della sintesi proteica.
Poichè sia il DBTC che il TBTC stimolano la sintesi di RNA, nel quarto capitolo
abbiamo utilizzato una tecnica moderna (cDNA macro array) per identificare i geni
attivati in seguito ad una breve esposizione di timociti al DBTC. Sono stati trovati due
geni, la glutatione S-trasferasi (GST) ed il nur77, entrambi coinvolti nel fenomeno
apoptotico indotto da diversi stimoli. La GST è un enzima di difesa, prodotto durante i
processi di detossificazione cellulare, mentre il nur77 è un membro della superfamiglia
dei recettori steroidei/tiroidei. Inibendo la trascrizione del nur77, la percentuale dei nuclei
apoptotici indotti dal DBTC è risultata notevolemente ridotta, confermando l’importanza
di questo gene nell’attivazione del processo apoptotico da parte degli stanno-derivati.
Oltre ai citati effetti sulla sintesi di macromolecole, il DBTC ed il TBTC sono in grado
di interferire con il metabolismo energetico e con i mitocondri. Nel quinto capitolo
abbiamo descritto il percorso, rivelatosi simile sia per il DBTC che per il TBTC, per
indurre l’apoptosi. In particolare, sono stati osservati un iniziale aumento di calcio
intracellulare, seguito dalla produzione di specie radicaliche a livello mitocondriale, dal
rilascio del citocromo c dalla membrana mitocondriale al citosol, e dall’attivazione della
caspasi 3 che porta la cellula alla frammentazione del DNA. Il fondamentale ruolo del
calcio e dei mitocondri nel processo apoptotico, è stato confermato dalla riduzione della
percentuale di apoptosi indotta dagli stanno-derivati in caso di aggiunta di chelatori del
calcio o di inibitori della catena di trasporto di elettroni.
Possiamo quindi affermare che l’apoptosi sia rilevante ad alte concentrazioni/dosi di
DBTC o TBTC, mentre piu’ basse concentrazioni/dosi di questi composti interferiscono
con la proliferazione cellulare senza attivare il fenomeno apoptotico.
Basandosi sul fatto che dati in letteratura riconoscono la capacità del DBTC di inibire in
vitro non solo i timociti ma anche le cellule spleniche, nell’ultimo capitolo abbiamo
esaminato se in vivo il composto fosse effettivamente selettivo verso il timo o avesse un
generale effetto immunosoppressivo. I risultati hanno rivelato che il DBTC direttamente e
rapidamente riduce il numero di cellule periferiche e di cellule formanti gli anticorpi
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(IgG) nei linfonodi auricolari di ratti precedentemente immuno-stimolati, indicando che il
timo non è l’unico bersaglio degli organostannici.
In conclusione, affermiamo che concentrazioni relativamente elevate degli stanno-
derivati DBTC e TBTC inducono apoptosi in vitro. Il processo apoptotico è dipendente
dalla sintesi di RNA e proteine ed inizia con un aumento di calcio, seguito dalla
produzione a livello mitocondriale di specie radicaliche, dal rilascio del citocromo c e
dall’attivazione delle caspasi. Inoltre, sono stati identificati due geni trascritti dopo
l’esposizione di timociti al DBTC e coinvolti nel processo apoptotico.
Studi in vivo rivelano che l’apoptosi non sia evidente a dosi di stanno-derivati in grado
di inibire la proliferazione di timociti.
Infine, il DBTC non è un composto selettivo per il timo, ma è in generale
immunosoppressivo.
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